EX-99.2 3 ex992qfsq419doc.htm EXHIBIT 99.2 Exhibit
Exhibit 99.2


 image0a42.jpg
Fourth Quarter
Financial Supplement
December 31, 2019
4




 
 
 
 
METLIFE
TABLE OF CONTENTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

1


 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
METLIFE
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
As used in this QFS, “MetLife," “we” and “our” refer to MetLife, Inc., a Delaware corporation incorporated in 1999, its subsidiaries and affiliates. In this QFS, MetLife presents certain measures of its performance that are not calculated in accordance with GAAP. We believe that these non-GAAP financial measures enhance the understanding of our performance by highlighting the results of operations and the underlying profitability drivers of our business. See Appendix for definitions of non-GAAP financial measures and other financial disclosures.
 
GAAP INTERIM CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
 
 
 
 
 
 
 
 
For the Three Months Ended
 
For the Year Ended
 
Unaudited (In millions)
 
December 31, 2018
 
March 31, 2019
 
June 30, 2019
 
September 30, 2019
 
December 31, 2019
 
 
December 31, 2018
 
December 31, 2019
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenues
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Premiums
 
$
9,267

 
$
9,405

 
$
10,129

 
$
10,781

 
$
11,920

 
 
$
43,840

 
$
42,235

 
 
Universal life and investment-type product policy fees
 
1,397

 
1,365

 
1,412

 
1,440

 
1,386

 
 
5,502

 
5,603

 
 
Net investment income
 
3,462

 
4,908

 
4,693

 
4,623

 
4,644

 
 
16,166

 
18,868

 
 
Other revenues
 
452

 
494

 
478

 
419

 
451

 
 
1,880

 
1,842

 
 
Net investment gains (losses)
 
145

 
15

 
61

 
161

 
207

 
 
(298
)
 
444

 
 
Net derivative gains (losses)
 
939

 
115

 
724

 
1,254

 
(1,465
)
 
 
851

 
628

 
 
Total revenues
 
15,662

 
16,302

 
17,497

 
18,678

 
17,143

 
 
67,941

 
69,620

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Expenses
 

 

 

 

 

 
 

 

 
 
Policyholder benefits and claims
 
8,992

 
9,072

 
9,993

 
10,648

 
11,748

 
 
42,656

 
41,461

 
 
Interest credited to policyholder account balances
 
486

 
1,961

 
1,515

 
1,500

 
1,488

 
 
4,013

 
6,464

 
 
Policyholder dividends
 
318

 
300

 
302

 
296

 
313

 
 
1,251

 
1,211

 
 
Capitalization of DAC
 
(814
)
 
(812
)
 
(837
)
 
(882
)
 
(827
)
 
 
(3,254
)
 
(3,358
)
 
 
Amortization of DAC and VOBA
 
843

 
624

 
689

 
797

 
786

 
 
2,975

 
2,896

 
 
Amortization of negative VOBA
 
(11
)
 
(10
)
 
(10
)
 
(4
)
 
(9
)
 
 
(56
)
 
(33
)
 
 
Interest expense on debt
 
260

 
234

 
274

 
223

 
224

 
 
1,122

 
955

 
 
Other expenses
 
3,117

 
3,189

 
3,274

 
3,309

 
3,457

 
 
12,927

 
13,229

 
 
Total expenses
 
13,191

 
14,558

 
15,200

 
15,887

 
17,180

 
 
61,634

 
62,825

 
 
Income (loss) from continuing operations before provision for income tax
 
2,471

 
1,744

 
2,297

 
2,791

 
(37
)
 
 
6,307

 
6,795

 
 
Provision for income tax expense (benefit)
 
409

 
359

 
551

 
601

 
(625
)
 
 
1,179

 
886

 
 
Income (loss) from continuing operations, net of income tax
 
2,062

 
1,385

 
1,746

 
2,190

 
588

 
 
5,128

 
5,909

 
 
Income (loss) from discontinued operations, net of income tax
 

 

 

 

 

 
 

 

 
 
Net income (loss)
 
2,062

 
1,385

 
1,746

 
2,190

 
588

 
 
5,128

 
5,909

 
 
Less: Net income (loss) attributable to noncontrolling interests
 
(5
)
 
4

 
5

 
6

 
(5
)
 
 
5

 
10

 
 
Net income (loss) attributable to MetLife, Inc.
 
2,067

 
1,381

 
1,741

 
2,184

 
593

 
 
5,123

 
5,899

 
 
Less: Preferred stock dividends
 
57

 
32

 
57

 
32

 
57

 
 
141

 
178

 
 
Net income (loss) available to MetLife, Inc.'s common shareholders
 
$
2,010

 
$
1,349

 
$
1,684

 
$
2,152

 
$
536

 
 
$
4,982

 
$
5,721

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Premiums, fees and other revenues
 
$
11,116

 
$
11,264

 
$
12,019

 
$
12,640

 
$
13,757

 
 
$
51,222

 
$
49,680

 

2


 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
METLIFE
CORPORATE OVERVIEW
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For the Three Months Ended
 
Unaudited (In millions, except per share data)
 
December 31, 2018

 
 
March 31, 2019

 
 
June 30, 2019

 
 
September 30, 2019

 
 
December 31, 2019

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss) available to MetLife, Inc.'s common shareholders
 
$
2,010

 
 
$
1,349

 
 
$
1,684

 
 
$
2,152

 
 
$
536

 
 
Adjustments from net income (loss) available to MetLife, Inc.'s common shareholders to adjusted earnings available to common shareholders:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Less: Net investment gains (losses)
 
145

 
 
15

 
 
61

 
 
161

 
 
207

 
 
Less: Net derivative gains (losses)
 
939

 
 
115

 
 
724

 
 
1,254

 
 
(1,465
)
 
 
Less: Goodwill impairment
 

 
 

 
 

 
 

 
 

 
 
Less: Other adjustments to continuing operations (1)
 
(202
)
 
 
(177
)
 
 
(179
)
 
 
(107
)
 
 
(418
)
 
 
Less: Provision for income tax (expense) benefit
 
(213
)
 
 
(24
)
 
 
(236
)
 
 
(340
)
 
 
373

 
 
Less: Income (loss) from discontinued operations, net of income tax
 

 
 

 
 

 
 

 
 

 
 
Add: Net income (loss) attributable to noncontrolling interests
 
(5
)
 
 
4

 
 
5

 
 
6

 
 
(5
)
 
 
Adjusted earnings available to common shareholders
 
$
1,336

 
 
$
1,424

 
 
$
1,319

 
 
$
1,190

 
 
$
1,834

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss) available to MetLife, Inc.'s common shareholders per diluted common share
 
$
2.04

 
 
$
1.40

 
 
$
1.77

 
 
$
2.30

 
 
$
0.58

 
 
Less: Net investment gains (losses)
 
0.15

 
 
0.02

 
 
0.06

 
 
0.17

 
 
0.22

 
 
Less: Net derivative gains (losses)
 
0.95

 
 
0.12

 
 
0.76

 
 
1.34

 
 
(1.58
)
 
 
Less: Goodwill impairment
 

 
 

 
 

 
 

 
 

 
 
Less: Other adjustments to continuing operations
 
(0.20
)
 
 
(0.19
)
 
 
(0.18
)
 
 
(0.11
)
 
 
(0.45
)
 
 
Less: Provision for income tax (expense) benefit
 
(0.22
)
 
 
(0.03
)
 
 
(0.24
)
 
 
(0.36
)
 
 
0.40

 
 
Less: Income (loss) from discontinued operations, net of income tax
 

 
 

 
 

 
 

 
 

 
 
Add: Net income (loss) attributable to noncontrolling interests
 
(0.01
)
 
 

 
 
0.01

 
 
0.01

 
 
(0.01
)
 
 
Adjusted earnings available to common shareholders per diluted common share
 
$
1.35

 
 
$
1.48

 
 
$
1.38

 
 
$
1.27

 
 
$
1.98

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For the Three Months Ended
 
Unaudited (In millions, except per share data) (2)
 
December 31, 2018

 
 
March 31, 2019

 
 
June 30, 2019

 
 
September 30, 2019

 
 
December 31, 2019

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Notable items impacting adjusted earnings available to common shareholders (3):
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Actuarial assumption review and other insurance adjustments
 
$

 
 
$

 
 
$

 
 
$
(160
)
 
 
$

 
 
Litigation reserves & settlement costs
 
(60
)
 
 

 
 

 
 

 
 

 
 
Expense initiative costs
 
(100
)
 
 
(55
)
 
 
(70
)
 
 
(88
)
 
 
(119
)
 
 
Interest on tax adjustments
 
170

 
 

 
 

 
 

 
 
64

 
 
Tax adjustments
 
77

 
 

 
 

 
 

 
 
475

 
 
Total notable items 
 
$
87

 
 
$
(55
)
 
 
$
(70
)
 
 
$
(248
)
 
 
$
420

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Notable items impacting adjusted earnings available to common shareholders per diluted common share (3):
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Actuarial assumption review and other insurance adjustments
 
$

 
 
$

 
 
$

 
 
$
(0.17
)
 
 
$

 
 
Litigation reserves & settlement costs
 
$
(0.06
)
 
 
$

 
 
$

 
 
$

 
 
$

 
 
Expense initiative costs
 
$
(0.10
)
 
 
$
(0.06
)
 
 
$
(0.07
)
 
 
$
(0.09
)
 
 
$
(0.13
)
 
 
Interest on tax adjustments
 
$
0.17

 
 
$

 
 
$

 
 
$

 
 
$
0.07

 
 
Tax adjustments
 
$
0.08

 
 
$

 
 
$

 
 
$

 
 
$
0.51

 
 
Total notable items 
 
$
0.09

 
 
$
(0.06
)
 
 
$
(0.07
)
 
 
$
(0.26
)
 
 
$
0.45

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For the Three Months Ended
 
Unaudited (In millions)
 
December 31, 2018

 
 
March 31, 2019

 
 
June 30, 2019

 
 
September 30, 2019

 
 
December 31, 2019

 
 
Weighted average common shares outstanding - diluted
 
987.6

 
 
963.3

 
 
952.9

 
 
936.4

 
 
925.7

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(1) See Page A-1 for further detail.
 
 
(2) Certain amounts in prior periods have been reclassified to conform to current period presentation.
 
 
(3) These notable items represent a positive (negative) impact to adjusted earnings available to common shareholders and adjusted earnings available to common shareholders per diluted common share. The per share data for each notable item is calculated on a standalone basis and may not sum to total notable items. Notable items reflect the unexpected impact of events that affect MetLife's results, but that were unknown and that MetLife could not anticipate when it devised its Business Plan. Notable items also include certain items regardless of the extent anticipated in the Business Plan to help investors have a better understanding of MetLife's results and to evaluate and forecast those results. See Pages A-2 and A-3 for further detail.
 


3


 
 
 
 
 
 
 
 
 
 
 
 
 
 
METLIFE
CORPORATE OVERVIEW (CONTINUED)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Unaudited
 
December 31, 2018

 
March 31, 2019

 
June 30, 2019

 
September 30, 2019

 
December 31, 2019

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Book value per common share (1)
 
$
51.53

 
$
58.06

 
$
64.61

 
$
70.71

 
$
68.62

 
 
Book value per common share, excluding AOCI other than FCTA (1)
 
$
44.62

 
$
45.58

 
$
47.09

 
$
48.56

 
$
48.97

 
 
Book value per common share - tangible common stockholders' equity (1)
 
$
34.77

 
$
35.71

 
$
37.09

 
$
38.52

 
$
38.86

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For the Three Months Ended
 
Unaudited
 
December 31, 2018

 
March 31, 2019

 
June 30, 2019

 
September 30, 2019

 
December 31, 2019

 
 
Return on MetLife, Inc.'s (2):
 
 
 
 
 
 
 
 
 
 
 
 
Common stockholders' equity
 
16.5
%
 
10.3
%
 
11.6
%
 
13.7
%
 
3.4
%
 
 
Common stockholders' equity, excluding AOCI other than FCTA
 
18.9
%
 
12.5
%
 
15.4
%
 
19.4
%
 
4.8
%
 
 
Tangible common stockholders' equity
 
24.4
%
 
16.2
%
 
19.7
%
 
24.6
%
 
6.1
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted return on MetLife, Inc.'s (2):
 
 
 
 
 
 
 
 
 
 
 
 
Common stockholders' equity
 
10.9
%
 
10.9
%
 
9.1
%
 
7.6
%
 
11.5
%
 
 
Common stockholders' equity, excluding AOCI other than FCTA
 
12.5
%
 
13.2
%
 
12.1
%
 
10.7
%
 
16.4
%
 
 
Tangible common stockholders' equity
 
16.2
%
 
17.1
%
 
15.5
%
 
13.7
%
 
20.7
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For the Three Months Ended
 
Unaudited (In millions)
 
December 31, 2018

 
March 31, 2019

 
June 30, 2019

 
September 30, 2019

 
December 31, 2019

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Common shares outstanding, beginning of period
 
986.6

 
958.6

 
950.2

 
935.9

 
919.6

 
 
Share repurchases
 
(28.4
)
 
(11.2
)
 
(15.8
)
 
(17.1
)
 
(5.1
)
 
 
Newly issued shares
 
0.4

 
2.8

 
1.5

 
0.8

 
0.8

 
 
Common shares outstanding, end of period
 
958.6

 
950.2

 
935.9

 
919.6

 
915.3

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Weighted average common shares outstanding - basic
 
980.3

 
956.5

 
946.2

 
929.6

 
918.7

 
 
Dilutive effect of the exercise or issuance of stock-based awards
 
7.3

 
6.8

 
6.7

 
6.8

 
7.0

 
 
Weighted average common shares outstanding - diluted
 
987.6

 
963.3

 
952.9

 
936.4

 
925.7

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MetLife Policyholder Trust Shares
 
148.0

 
146.2

 
144.3

 
142.8

 
140.7

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(1) Calculated using common shares outstanding, end of period.
 
 
(2) Annualized using quarter-to-date results. See Page A-4 for further detail.
 


4


 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
METLIFE
KEY ADJUSTED EARNINGS STATEMENT LINE ITEMS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For the Three Months Ended
 
For the Year Ended
 
Unaudited (In millions)
 
December 31, 2018

 
March 31, 2019

 
June 30, 2019

 
September 30, 2019

 
December 31, 2019

 
 
December 31, 2018


December 31, 2019

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total revenues
 
$
15,662

 
$
16,302

 
$
17,497

 
$
18,678

 
$
17,143

 
 
$
67,941

 
$
69,620

 
 
Less: Net investment gains (losses)
 
145

 
15

 
61

 
161

 
207

 
 
(298
)
 
444

 
 
Less: Net derivative gains (losses)
 
939

 
115

 
724

 
1,254

 
(1,465
)
 
 
851

 
628

 
 
Less: Adjustments related to net investment gains (losses) and net derivative gains (losses)
 
(8
)
 

 
20

 
59

 
18

 
 
(7
)
 
97

 
 
Less: Other adjustments to revenues:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
GMIB fees
 
27

 
27

 
28

 
27

 
26

 
 
120

 
108

 
 
Investment hedge adjustments
 
(121
)
 
(105
)
 
(118
)
 
(121
)
 
(125
)
 
 
(475
)
 
(469
)
 
 
Operating joint venture adjustments
 

 

 

 

 

 
 
1

 

 
 
Unit-linked contract income
 
(765
)
 
736

 
261

 
250

 
228

 
 
(683
)
 
1,475

 
 
Securitization entities income
 

 

 

 

 

 
 

 

 
 
Certain partnership distributions
 
(27
)
 
(4
)
 
(4
)
 
(2
)
 
(5
)
 
 
(61
)
 
(15
)
 
 
Settlement of foreign currency earnings hedges
 
5

 
2

 
2

 
3

 
2

 
 
19

 
9

 
 
TSA fees
 
70

 
68

 
69

 
69

 
40

 
 
305

 
246

 
 
Divested businesses
 

 

 

 
60

 
63

 
 
8

 
123

 
 
Total adjusted revenues
 
$
15,397

 
$
15,448

 
$
16,454

 
$
16,918

 
$
18,154

 
 
$
68,161

 
$
66,974

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For the Three Months Ended
 
For the Year Ended
 
Unaudited (In millions)
 
December 31, 2018

 
March 31, 2019

 
June 30, 2019

 
September 30, 2019

 
December 31, 2019

 
 
December 31, 2018

 
December 31, 2019

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
 
$
3,462

 
$
4,908

 
$
4,693

 
$
4,623

 
$
4,644

 
 
$
16,166

 
$
18,868

 
 
Less: Adjustments to net investment income:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investment hedge adjustments
 
(121
)
 
(105
)
 
(118
)
 
(121
)
 
(125
)
 
 
(475
)
 
(469
)
 
 
Operating joint venture adjustments
 

 

 

 

 

 
 
1

 

 
 
Unit-linked contract income
 
(765
)
 
736

 
261

 
250

 
228

 
 
(683
)
 
1,475

 
 
Securitization entities income
 

 

 

 

 

 
 

 

 
 
Certain partnership distributions
 
(27
)
 
(4
)
 
(4
)
 
(2
)
 
(5
)
 
 
(61
)
 
(15
)
 
 
Divested businesses
 

 

 

 
23

 
24

 
 
1

 
47

 
 
Net investment income, as reported on an adjusted basis
 
$
4,375

 
$
4,281

 
$
4,554

 
$
4,473

 
$
4,522

 
 
$
17,383

 
$
17,830

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For the Three Months Ended
 
For the Year Ended
 
Unaudited (In millions)
 
December 31, 2018

 
March 31, 2019

 
June 30, 2019

 
September 30, 2019

 
December 31, 2019

 
 
December 31, 2018

 
December 31, 2019

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Premiums, fees and other revenues
 
$
11,116

 
$
11,264

 
$
12,019

 
$
12,640

 
$
13,757

 
 
$
51,222

 
$
49,680

 
 
Less: Adjustments to premiums, fees and other revenues:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Unearned revenue adjustments
 
(8
)
 

 
20

 
59

 
18

 
 
(7
)
 
97

 
 
GMIB fees
 
27

 
27

 
28

 
27

 
26

 
 
120

 
108

 
 
Settlement of foreign currency earnings hedges
 
5

 
2

 
2

 
3

 
2

 
 
19

 
9

 
 
TSA fees
 
70

 
68

 
69

 
69

 
40

 
 
305

 
246

 
 
Divested businesses
 

 

 

 
37

 
39

 
 
7

 
76

 
 
Adjusted premiums, fees and other revenues
 
$
11,022

 
$
11,167

 
$
11,900

 
$
12,445

 
$
13,632

 
 
$
50,778

 
$
49,144

 
 
Adjusted premiums, fees and other revenues, on a constant currency basis
 
$
11,019

 
$
11,109

 
$
11,858

 
$
12,411

 
$
13,632

 
 
 
 
 
 

5


 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
METLIFE
KEY ADJUSTED EARNINGS STATEMENT LINE ITEMS (CONTINUED)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For the Three Months Ended
 
For the Year Ended
 
Unaudited (In millions)
December 31, 2018

 
March 31, 2019

 
June 30, 2019

 
September 30, 2019

 
December 31, 2019

 
 
December 31, 2018

 
December 31, 2019

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total expenses
$
13,191

 
$
14,558

 
$
15,200

 
$
15,887

 
$
17,180

 
 
$
61,634

 
$
62,825

 
 
Less: Adjustments related to net investment gains (losses) and net derivative gains (losses)
44

 
(24
)
 
(5
)
 
39

 
106

 
 
109

 
116

 
 
Less: Goodwill impairment

 

 

 

 

 
 

 

 
 
Less: Other adjustments to expenses:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PBC hedge adjustment

 

 

 
9

 
10

 
 

 
19

 
 
Inflation and pass-through adjustments
1

 
79

 
84

 
87

 
(6
)
 
 
29

 
244

 
 
GMIB costs and amortization of DAC and VOBA related to GMIB fees and GMIB costs
(10
)
 
49

 
36

 
(47
)
 
105

 
 
252

 
143

 
 
Market value adjustments and amortization of DAC, VOBA and negative VOBA related to market value adjustments
(1
)
 
(4
)
 
(11
)
 
3

 
8

 
 
(2
)
 
(4
)
 
 
PAB hedge adjustments
(1
)
 
(3
)
 
(6
)
 
(5
)
 
(5
)
 
 
(4
)
 
(19
)
 
 
Unit-linked contract costs
(730
)
 
716

 
257

 
223

 
240

 
 
(676
)
 
1,436

 
 
Securitization entities debt expense

 

 

 

 

 
 

 

 
 
Noncontrolling interest
5

 
(6
)
 
(6
)
 
(8
)
 
5

 
 
(10
)
 
(15
)
 
 
Regulatory implementation costs
5

 
3

 
7

 
5

 
3

 
 
11

 
18

 
 
Acquisition, integration and other costs
(14
)
 
23

 
6

 
8

 
7

 
 
24

 
44

 
 
TSA fees
70

 
68


69


69


40


 
305


246


 
Divested businesses
14

 

 
6

 
69

 
152

 
 
130

 
227

 
 
Total adjusted expenses
$
13,808

 
$
13,657

 
$
14,763

 
$
15,435

 
$
16,515

 
 
$
61,466

 
$
60,370

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For the Three Months Ended
 
For the Year Ended
 
Unaudited (In millions)
December 31, 2018

 
March 31, 2019

 
June 30, 2019

 
September 30, 2019

 
December 31, 2019

 
 
December 31, 2018

 
December 31, 2019

 
 
 
 
 
 
 
 
 
 
 


 
 
 
 
 
 
 
Capitalization of DAC
$
(814
)
 
$
(812
)
 
$
(837
)
 
$
(882
)
 
$
(827
)
 
 
$
(3,254
)
 
$
(3,358
)
 
 
Less: Divested businesses

 

 

 
(11
)
 
(9
)
 
 
(1
)
 
(20
)
 
 
Capitalization of DAC, as reported on an adjusted basis
$
(814
)
 
$
(812
)
 
$
(837
)
 
$
(871
)
 
$
(818
)
 
 
$
(3,253
)
 
$
(3,338
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For the Three Months Ended
 
For the Year Ended
 
Unaudited (In millions)
December 31, 2018

 
March 31, 2019

 
June 30, 2019

 
September 30, 2019

 
December 31, 2019

 
 
December 31, 2018

 
December 31, 2019

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Other expenses
$
3,117

 
$
3,189

 
$
3,274

 
$
3,309

 
$
3,457

 
 
$
12,927

 
$
13,229

 
 
Less: Noncontrolling interest
5

 
(6
)
 
(6
)
 
(8
)
 
5

 
 
(10
)
 
(15
)
 
 
Less: Regulatory implementation costs
5

 
3

 
7

 
5

 
3

 
 
11

 
18

 
 
Less: Acquisition, integration and other costs
(14
)
 
23

 
6

 
8

 
7

 
 
24

 
44

 
 
Less: TSA fees
70

 
68

 
69

 
69

 
40

 
 
305

 
246

 
 
Less: Divested businesses
(4
)
 

 
6

 
36

 
116

 
 
68

 
158

 
 
Other expenses, as reported on an adjusted basis
$
3,055

 
$
3,101

 
$
3,192

 
$
3,199

 
$
3,286

 
 
$
12,529

 
$
12,778

 
 
Other expenses, as reported on an adjusted basis, on a constant currency basis
$
3,059

 
$
3,081

 
$
3,181

 
$
3,186

 
$
3,286

 
 
 
 
 
 


6


 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
METLIFE
EXPENSE DETAIL AND RATIOS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For the Three Months Ended
 
For the Year Ended
 
Unaudited (In millions, except ratio data)
December 31, 2018

 
March 31, 2019

 
June 30, 2019

 
September 30, 2019

 
December 31, 2019

 
 
December 31, 2018

 
December 31, 2019

 
 
Other expenses
$
3,117

 
$
3,189

 
$
3,274

 
$
3,309

 
$
3,457

 
 
$
12,927

 
$
13,229

 
 
Capitalization of DAC
(814
)
 
(812
)
 
(837
)
 
(882
)
 
(827
)
 
 
(3,254
)
 
(3,358
)
 
 
Other expenses, net of capitalization of DAC
$
2,303

 
$
2,377

 
$
2,437

 
$
2,427

 
$
2,630

 
 
$
9,673

 
$
9,871

 
 
 


 
 
 
 
 
 
 


 
 
 
 
 
 
 
Premiums, fees and other revenues
$
11,116

 
$
11,264

 
$
12,019

 
$
12,640

 
$
13,757

 
 
$
51,222

 
$
49,680

 
 
 


 
 
 
 
 
 
 


 
 
 
 
 
 
 
Expense ratio
20.7
%
 
21.1
%
 
20.3
%
 
19.2
%
 
19.1
%
 
 
18.9
%
 
19.9
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For the Three Months Ended
 
For the Year Ended
 
Unaudited (In millions)
December 31, 2018

 
March 31, 2019

 
June 30, 2019

 
September 30, 2019

 
December 31, 2019

 
 
December 31, 2018

 
December 31, 2019

 
 
Other expenses by major category, as reported on an adjusted basis


 


 


 


 


 
 


 


 
 
Direct expenses
$
1,369

 
$
1,420

 
$
1,485

 
$
1,475

 
$
1,597

 
 
$
5,874

 
$
5,977

 
 
Pension, postretirement and postemployment benefit costs
44

 
56

 
57

 
57

 
63

 
 
185

 
233

 
 
Premium taxes, other taxes, and licenses & fees
197

 
170

 
174

 
164

 
165

 
 
755

 
673

 
 
Commissions and other variable expenses
1,445

 
1,455

 
1,476

 
1,503

 
1,461

 
 
5,715

 
5,895

 
 
Other expenses, as reported on an adjusted basis
3,055

 
3,101

 
3,192

 
3,199

 
3,286

 
 
12,529

 
12,778

 
 
Capitalization of DAC, as reported on an adjusted basis
(814
)
 
(812
)
 
(837
)
 
(871
)
 
(818
)
 
 
(3,253
)
 
(3,338
)
 
 
Other expenses, net of capitalization of DAC, as reported on an adjusted basis
2,241

 
2,289

 
2,355

 
2,328

 
2,468

 
 
9,276

 
9,440

 
 
Less: Total notable items related to other expenses, as reported on an adjusted basis (1)
(19
)
 
70

 
88

 
111

 
69

 
 
214

 
338

 
 
Other expenses, net of capitalization of DAC, excluding total notable items related to other expenses, as reported on an adjusted basis (1)
$
2,260

 
$
2,219

 
$
2,267

 
$
2,217

 
$
2,399

 
 
$
9,062

 
$
9,102

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For the Three Months Ended
 
For the Year Ended
 
Unaudited (In millions, except ratio data)
December 31, 2018

 
March 31, 2019

 
June 30, 2019

 
September 30, 2019

 
December 31, 2019

 
 
December 31, 2018

 
December 31, 2019

 
 
Employee related costs
$
912

 
$
922

 
$
916

 
$
871

 
$
948

 
 
$
3,664

 
$
3,657

 
 
Third party staffing costs
486

 
375

 
419

 
422

 
536

 
 
1,703

 
1,752

 
 
General and administrative expenses
(29
)
 
123

 
150

 
182

 
113

 
 
507

 
568

 
 
Direct expenses
1,369

 
1,420

 
1,485

 
1,475

 
1,597

 
 
5,874

 
5,977

 
 
Less: Total notable items related to direct expenses (1)
(19
)
 
70

 
88

 
111

 
69

 
 
214

 
338

 
 
Direct expenses, excluding total notable items related to direct expenses (1)
$
1,388

 
$
1,350

 
$
1,397

 
$
1,364

 
$
1,528

 
 
$
5,660

 
$
5,639

 
 
 


 


 


 


 


 
 


 


 
 
Other expenses, net of capitalization of DAC, as reported on an adjusted basis
$
2,241

 
$
2,289

 
$
2,355

 
$
2,328

 
$
2,468

 
 
$
9,276

 
$
9,440

 
 
Less: Total notable items related to other expenses, as reported on an adjusted basis (1)
(19
)
 
70

 
88

 
111

 
69

 
 
214

 
338

 
 
Other expenses, net of capitalization of DAC, excluding total notable items related to other expenses, as reported on an adjusted basis (1)
$
2,260

 
$
2,219

 
$
2,267

 
$
2,217

 
$
2,399

 
 
$
9,062

 
$
9,102

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted premiums, fees and other revenues
$
11,022

 
$
11,167

 
$
11,900

 
$
12,445

 
$
13,632

 
 
$
50,778

 
$
49,144

 
 
Less: PRT
(76
)
 
(2
)
 
556

 
1,293

 
2,499

 
 
6,894

 
4,346

 
 
Adjusted premiums, fees and other revenues, excluding PRT
$
11,098

 
$
11,169

 
$
11,344

 
$
11,152

 
$
11,133

 
 
$
43,884

 
$
44,798

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Direct expense ratio
12.4
%
 
12.7
%
 
12.5
%
 
11.9
%
 
11.7
%
 
 
11.6
%
 
12.2
%
 
 
Direct expense ratio, excluding total notable items related to direct expenses and PRT (1)
12.5
%
 
12.1
%
 
12.3
%
 
12.2
%
 
13.7
%
 
 
12.9
%
 
12.6
%
 
 
 


 


 


 


 


 
 


 


 
 
Adjusted expense ratio
20.3
%
 
20.5
%
 
19.8
%
 
18.7
%
 
18.1
%
 
 
18.3
%
 
19.2
%
 
 
Adjusted expense ratio, excluding total notable items related to other expenses and PRT (1)
20.4
%
 
19.9
%
 
20.0
%
 
19.9
%
 
21.5
%
 
 
20.6
%
 
20.3
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(1) Notable items are related to “litigation reserves & settlement costs”, “interest (expense) income on tax adjustments” and “expense initiative costs”. Notable items reflect the unexpected impact of events that affect MetLife’s results, but that were unknown and that MetLife could not anticipate when it devised its Business Plan. Notable items also include certain items regardless of the extent anticipated in the Business Plan to help investors have a better understanding of MetLife's results and to evaluate and forecast those results. Notable items can affect MetLife’s results either positively or negatively. See Pages A-2 and A-3 for further detail.
 


7


 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
METLIFE
CONSOLIDATED BALANCE SHEETS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Unaudited (In millions)
 
December 31, 2018

 
 
March 31, 2019

 
 
June 30, 2019

 
 
September 30, 2019

 
 
December 31, 2019

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ASSETS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investments:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fixed maturity securities available-for-sale, at estimated fair value
 
$
298,265

 
 
$
308,410

 
 
$
318,689

 
 
$
326,049

 
 
$
327,820

 
 
Equity securities, at estimated fair value
 
1,440

 
 
1,432

 
 
1,476

 
 
1,341

 
 
1,342

 
 
Contractholder-directed equity securities and fair value option securities, at estimated fair value
 
12,616

 
 
13,245

 
 
13,000

 
 
12,671

 
 
13,102

 
 
Mortgage loans
 
75,752

 
 
78,601

 
 
77,997

 
 
78,959

 
 
80,529

 
 
Policy loans
 
9,699

 
 
9,670

 
 
9,705

 
 
9,671

 
 
9,680

 
 
Real estate and real estate joint ventures
 
9,698

 
 
10,022

 
 
10,326

 
 
10,246

 
 
10,741

 
 
Other limited partnership interests
 
6,613

 
 
6,787

 
 
7,054

 
 
7,441

 
 
7,716

 
 
Short-term investments, principally at estimated fair value
 
3,937

 
 
4,524

 
 
2,811

 
 
3,536

 
 
3,850

 
 
Other invested assets
 
18,190

 
 
18,175

 
 
20,036

 
 
21,979

 
 
19,015

 
 
Total investments
 
436,210

 
 
450,866

 
 
461,094

 
 
471,893

 
 
473,795

 
 
Cash and cash equivalents, principally at estimated fair value
 
15,821

 
 
14,506

 
 
18,435

 
 
19,452

 
 
16,598

 
 
Accrued investment income
 
3,582

 
 
3,569

 
 
3,535

 
 
3,561

 
 
3,523

 
 
Premiums, reinsurance and other receivables
 
19,644

 
 
20,615

 
 
20,425

 
 
20,723

 
 
20,443

 
 
Deferred policy acquisition costs and value of business acquired
 
18,895

 
 
18,349

 
 
17,880

 
 
17,382

 
 
17,833

 
 
Current income tax recoverable
 

 
 

 
 
97

 
 

 
 

 
 
Goodwill
 
9,422

 
 
9,418

 
 
9,408

 
 
9,278

 
 
9,308

 
 
Other assets
 
8,408

 
 
10,100

 
 
10,029

 
 
10,166

 
 
10,518

 
 
Separate account assets
 
175,556

 
 
185,765

 
 
191,264

 
 
190,357

 
 
188,445

 
 
Total assets
 
$
687,538

 
 
$
713,188

 
 
$
732,167

 
 
$
742,812

 
 
$
740,463

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LIABILITIES AND EQUITY
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Liabilities
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Future policy benefits
 
$
186,780

 
 
$
187,508

 
 
$
191,139

 
 
$
193,310

 
 
$
194,909

 
 
Policyholder account balances
 
183,693

 
 
187,333

 
 
190,033

 
 
189,060

 
 
192,627

 
 
Other policy-related balances
 
16,529

 
 
16,967

 
 
16,815

 
 
16,960

 
 
17,171

 
 
Policyholder dividends payable
 
677

 
 
671

 
 
689

 
 
692

 
 
681

 
 
Policyholder dividend obligation
 
428

 
 
1,116

 
 
1,834

 
 
2,370

 
 
2,020

 
 
Payables for collateral under securities loaned and other transactions
 
24,794

 
 
25,084

 
 
25,354

 
 
28,443

 
 
26,745

 
 
Short-term debt
 
268

 
 
289

 
 
158

 
 
142

 
 
235

 
 
Long-term debt
 
12,829

 
 
12,850

 
 
13,346

 
 
13,443

 
 
13,466

 
 
Collateral financing arrangements
 
1,060

 
 
1,048

 
 
1,026

 
 
1,013

 
 
993

 
 
Junior subordinated debt securities
 
3,147

 
 
3,148

 
 
3,149

 
 
3,149

 
 
3,150

 
 
Current income tax payable
 
441

 
 
505

 
 

 
 
31

 
 
363

 
 
Deferred income tax liability
 
5,414

 
 
7,075

 
 
8,766

 
 
10,153

 
 
9,097

 
 
Other liabilities
 
22,964

 
 
25,091

 
 
24,548

 
 
25,070

 
 
24,179

 
 
Separate account liabilities
 
175,556

 
 
185,765

 
 
191,264

 
 
190,357

 
 
188,445

 
 
Total liabilities
 
634,580

 
 
654,450

 
 
668,121

 
 
674,193

 
 
674,081

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Equity
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Preferred stock, at par value
 

 
 

 
 

 
 

 
 

 
 
Common stock, at par value
 
12

 
 
12

 
 
12

 
 
12

 
 
12

 
 
Additional paid-in capital
 
32,474

 
 
32,535

 
 
32,602

 
 
32,639

 
 
32,680

 
 
Retained earnings
 
28,926

 
 
29,944

 
 
31,209

 
 
32,948

 
 
33,078

 
 
Treasury stock, at cost
 
(10,393
)
 
 
(10,893
)
 
 
(11,643
)
 
 
(12,428
)
 
 
(12,678
)
 
 
Accumulated other comprehensive income (loss)
 
1,722

 
 
6,911

 
 
11,631

 
 
15,197

 
 
13,052

 
 
Total MetLife, Inc.'s stockholders' equity
 
52,741

 
 
58,509

 
 
63,811

 
 
68,368

 
 
66,144

 
 
Noncontrolling interests
 
217

 
 
229

 
 
235

 
 
251

 
 
238

 
 
Total equity
 
52,958

 
 
58,738

 
 
64,046

 
 
68,619

 
 
66,382

 
 
Total liabilities and equity
 
$
687,538

 
 
$
713,188

 
 
$
732,167

 
 
$
742,812

 
 
$
740,463

 


8


 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
METLIFE
SUMMARY OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
For the Three Months Ended
 
 
Unaudited (In millions)
 
December 31, 2018
 
 
March 31, 2019
 
 
June 30, 2019
 
 
September 30, 2019
 
 
December 31, 2019
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted earnings before provision for income tax
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
U.S.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
GROUP BENEFITS
 
$
297

 
 
$
433

 
 
$
393

 
 
$
464

 
 
$
416

 
 
RETIREMENT AND INCOME SOLUTIONS
 
450

 
 
358

 
 
442

 
 
357

 
 
404

 
 
PROPERTY & CASUALTY
 
120

 
 
117

 
 
84

 
 
67

 
 
27

 
 
TOTAL U.S.
 
$
867

 
 
$
908

 
 
$
919

 
 
$
888

 
 
$
847

 
 
ASIA
 
392

 
 
505

 
 
516

 
 
501

 
 
468

 
 
LATIN AMERICA
 
180

 
 
196

 
 
216

 
 
220

 
 
204

 
 
EMEA
 
81

 
 
113

 
 
99

 
 
74

 
 
71

 
 
METLIFE HOLDINGS
 
283

 
 
395

 
 
372

 
 
183

 
 
333

 
 
CORPORATE & OTHER
 
(214
)
 
 
(326
)
 
 
(431
)
 
 
(383
)
 
 
(284
)
 
 
Total adjusted earnings before provision for income tax
 
$
1,589

 
 
$
1,791

 
 
$
1,691

 
 
$
1,483

 
 
$
1,639

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Provision for income tax expense (benefit)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
U.S.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
GROUP BENEFITS
 
$
67

 
 
$
91

 
 
$
82

 
 
$
98

 
 
$
87

 
 
RETIREMENT AND INCOME SOLUTIONS
 
94

 
 
73

 
 
91

 
 
73

 
 
83

 
 
PROPERTY & CASUALTY
 
21

 
 
20

 
 
14

 
 
10

 
 
2

 
 
TOTAL U.S.
 
$
182

 
 
$
184

 
 
$
187

 
 
$
181

 
 
$
172

 
 
ASIA
 
111

 
 
149

 
 
157

 
 
152

 
 
127

 
 
LATIN AMERICA
 
43

 
 
62

 
 
57

 
 
65

 
 
43

 
 
EMEA
 
26

 
 
27

 
 
22

 
 
21

 
 
5

 
 
METLIFE HOLDINGS
 
60

 
 
78

 
 
73

 
 
34

 
 
64

 
 
CORPORATE & OTHER
 
(226
)
 
 
(165
)
 
 
(181
)
 
 
(192
)
 
 
(663
)
 
 
Total provision for income tax expense (benefit)
 
$
196

 
 
$
335

 
 
$
315

 
 
$
261

 
 
$
(252
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted earnings available to common shareholders
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
U.S.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
GROUP BENEFITS
 
$
230

 
 
$
342

 
 
$
311

 
 
$
366

 
 
$
329

 
 
RETIREMENT AND INCOME SOLUTIONS
 
356

 
 
285

 
 
351

 
 
284

 
 
321

 
 
PROPERTY & CASUALTY
 
99

 
 
97

 
 
70

 
 
57

 
 
25

 
 
TOTAL U.S.
 
$
685

 
 
$
724

 
 
$
732

 
 
$
707

 
 
$
675

 
 
ASIA
 
281

 
 
356

 
 
359

 
 
349

 
 
341

 
 
LATIN AMERICA
 
137

 
 
134

 
 
159

 
 
155

 
 
161

 
 
EMEA
 
55

 
 
86

 
 
77

 
 
53

 
 
66

 
 
METLIFE HOLDINGS
 
223

 
 
317

 
 
299

 
 
149

 
 
269

 
 
CORPORATE & OTHER (1)
 
(45
)
 
 
(193
)
 
 
(307
)
 
 
(223
)
 
 
322

 
 
Total adjusted earnings available to common shareholders (1)
 
$
1,336

 
 
$
1,424

 
 
$
1,319

 
 
$
1,190

 
 
$
1,834

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(1) Includes impact of preferred stock dividends of $57 million, $32 million, $57 million, $32 million and $57 million for the three months ended December 31, 2018, March 31, 2019, June 30, 2019, September 30, 2019 and December 31, 2019, respectively.

9


 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
METLIFE
ADJUSTED RETURN ON ALLOCATED EQUITY AND ALLOCATED TANGIBLE EQUITY (1), (2)
 
 
 
 
ADJUSTED RETURN ON ALLOCATED EQUITY
 
  
 
For the Three Months Ended
 
 
Unaudited
 
December 31, 2018
 
March 31, 2019
 
June 30, 2019
 
September 30, 2019
 
 
December 31, 2019
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
U.S.
 
 
 
 
 
 
 
 
 
 
 
 
 
GROUP BENEFITS
 
32.9
%
 
48.6
%
 
44.2
%
 
52.0
%
 
 
46.7
%
 
 
RETIREMENT AND INCOME SOLUTIONS
 
22.9
%
 
19.4
%
 
23.9
%
 
19.3
%
 
 
21.9
%
 
 
PROPERTY & CASUALTY
 
21.4
%
 
19.2
%
 
13.9
%
 
11.3
%
 
 
5.0
%
 
 
TOTAL U.S.
 
25.2
%
 
27.0
%
 
27.3
%
 
26.4
%
 
 
25.2
%
 
 
ASIA
 
7.9
%
 
10.0
%
 
10.1
%
 
9.8
%
 
 
9.6
%
 
 
LATIN AMERICA
 
17.5
%
 
18.1
%
 
21.5
%
 
20.9
%
 
 
21.7
%
 
 
EMEA
 
6.3
%
 
12.3
%
 
11.0
%
 
7.6
%
 
 
9.4
%
 
 
METLIFE HOLDINGS
 
8.9
%
 
13.2
%
 
12.5
%
 
6.2
%
 
 
11.2
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ADJUSTED RETURN ON ALLOCATED TANGIBLE EQUITY (3)
 
 
  
 
For the Three Months Ended
 
 
Unaudited
 
December 31, 2018
 
March 31, 2019
 
June 30, 2019
 
September 30, 2019
 
 
December 31, 2019
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
U.S.
 
29.2
%
 
30.7
%
 
31.0
%
 
30.0
%
 
 
28.6
%
 
 
ASIA
 
12.0
%
 
15.2
%
 
15.3
%
 
14.9
%
 
 
14.6
%
 
 
LATIN AMERICA
 
29.1
%
 
29.9
%
 
35.5
%
 
34.6
%
 
 
36.0
%
 
 
EMEA
 
10.5
%
 
22.1
%
 
19.8
%
 
13.8
%
 
 
16.8
%
 
 
METLIFE HOLDINGS
 
10.0
%
 
14.8
%
 
14.0
%
 
7.1
%
 
 
12.5
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(1) Annualized using quarter-to-date results.
 
(2) Allocated equity and allocated tangible equity are presented below:
 
 
  
 
 
ALLOCATED EQUITY
 
ALLOCATED TANGIBLE EQUITY
 
 
 
Unaudited (In millions)
 
 
2018
 
2019
 
2018
 
 
2019
 
 
 
U.S.
 
 
 
 
 
 
 
 
 
 
 
 
 
GROUP BENEFITS
 
 
$
2,797

 
$
2,817

 
 
 
 
 
 
 
 
RETIREMENT AND INCOME SOLUTIONS
 
 
6,209

 
5,876

 
 
 
 
 
 
 
 
PROPERTY & CASUALTY
 
 
1,851

 
2,020

 
 
 
 
 
 
 
 
TOTAL U.S.
 
 
$
10,857

 
$
10,713

 
$
9,389

 
 
$
9,447

 
 
 
ASIA
 
 
$
14,260

 
$
14,274

 
$
9,456

 
 
$
9,396

 
 
 
LATIN AMERICA
 
 
$
3,139

 
$
2,965

 
$
1,880

 
 
$
1,791

 
 
 
EMEA
 
 
$
3,473

 
$
2,802

 
$
2,176

 
 
$
1,595

 
 
 
METLIFE HOLDINGS
 
 
$
10,063

 
$
9,599

 
$
9,066

 
 
$
8,715

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(3) Adjusted earnings available to common shareholders used to calculate the adjusted return on allocated tangible equity excludes the impact of amortization on VODA and VOCRA, net of income tax, as presented below:
 
 
 
 
For the Three Months Ended
 
 
 
Unaudited (In millions)
 
December 31, 2018

 
March 31, 2019

 
June 30, 2019

 
September 30, 2019

 
 
December 31, 2019

 
 
 
U.S.
 
$
1

 
$
1

 
$
1

 
$
1

 
 
$

 
 
 
ASIA
 
$
2

 
$
2

 
$
1

 
$
1

 
 
$
2

 
 
 
LATIN AMERICA
 
$

 
$

 
$

 
$

 
 
$

 
 
 
EMEA
 
$
2

 
$
2

 
$
2

 
$
2

 
 
$
1

 
 
 
METLIFE HOLDINGS
 
$
4

 
$
5

 
$
5

 
$
5

 
 
$
3

 


10


 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
U.S.
STATEMENTS OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS

 
 
 
  
For the Three Months Ended
 
 
For the Year Ended
 
Unaudited (In millions)
 
December 31, 2018

 
March 31, 2019

 
June 30, 2019

 
September 30, 2019

 
December 31, 2019

 
 
December 31, 2018

 
December 31, 2019

 
 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted revenues
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Premiums
 
$
5,236

 
$
5,567

 
$
6,234

 
$
6,903

 
$
8,097

 
 
$
28,186

 
$
26,801

 
 
Universal life and investment-type product policy fees
 
281

 
270

 
274

 
264

 
270

 
 
1,053

 
1,078

 
 
Net investment income
 
1,809

 
1,719

 
1,795

 
1,760

 
1,747

 
 
6,977

 
7,021

 
 
Other revenues
 
208

 
221

 
223

 
224

 
219

 
 
821

 
887

 
 
Total adjusted revenues
 
7,534

 
7,777

 
8,526

 
9,151

 
10,333

 
 
37,037

 
35,787

 
 

 

 

 

 

 
 
 
 
 
 
 
 
 
Adjusted expenses
 

 

 

 

 
 
 
 
 
 
 
 
 
Policyholder benefits and claims and policyholder dividends
 
5,175

 
5,373

 
6,101

 
6,759

 
7,932

 
 
27,765

 
26,165

 
 
Interest credited to policyholder account balances
 
487

 
501

 
504

 
507

 
472

 
 
1,790

 
1,984

 
 
Capitalization of DAC
 
(113
)
 
(114
)
 
(127
)
 
(131
)
 
(112
)
 
 
(449
)
 
(484
)
 
 
Amortization of DAC and VOBA
 
120

 
114

 
117

 
121

 
123

 
 
477

 
475

 
 
Amortization of negative VOBA
 

 

 

 

 

 
 

 

 
 
Interest expense on debt
 
4

 
2

 
3

 
3

 
2

 
 
12

 
10

 
 
Other expenses
 
994

 
993

 
1,009

 
1,004

 
1,069

 
 
3,902

 
4,075

 
 
Total adjusted expenses
 
6,667

 
6,869

 
7,607

 
8,263

 
9,486

 
 
33,497

 
32,225

 
 
Adjusted earnings before provision for income tax
 
867

 
908

 
919

 
888

 
847

 
 
3,540

 
3,562

 
 
Provision for income tax expense (benefit)
 
182

 
184

 
187

 
181

 
172

 
 
736

 
724

 
 
Adjusted earnings
 
685

 
724

 
732

 
707

 
675

 
 
2,804

 
2,838

 
 
Preferred stock dividends
 

 

 

 

 

 
 

 

 
 
Adjusted earnings available to common shareholders
 
$
685

 
$
724

 
$
732

 
$
707

 
$
675

 
 
$
2,804

 
$
2,838

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted premiums, fees and other revenues
 
$
5,725

 
$
6,058

 
$
6,731

 
$
7,391

 
$
8,586

 
 
$
30,060

 
$
28,766

 
 
Less: PRT
 
(76
)
 
(2
)
 
556

 
1,293

 
2,499

 
 
6,894

 
4,346

 
 
Adjusted premiums, fees and other revenues, excluding PRT
 
$
5,801

 
$
6,060

 
$
6,175

 
$
6,098

 
$
6,087

 
 
$
23,166

 
$
24,420

 

11


 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
U.S.
GROUP BENEFITS
STATEMENTS OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS
 
 
 
For the Three Months Ended
 
For the Year Ended
 
Unaudited (In millions)
 
December 31, 2018

 
March 31, 2019

 
June 30, 2019

 
September 30, 2019

 
December 31, 2019

 
 
December 31, 2018

 
December 31, 2019

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted revenues
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Premiums
 
$
3,949

 
$
4,208

 
$
4,247

 
$
4,239

 
$
4,217

 
 
$
16,082

 
$
16,911

 
 
Universal life and investment-type product policy fees
 
202

 
194

 
203

 
198

 
194

 
 
804

 
789

 
 
Net investment income
 
275

 
280

 
292

 
293

 
297

 
 
1,127

 
1,162

 
 
Other revenues
 
132

 
143

 
144

 
145

 
143

 
 
515

 
575

 
 
Total adjusted revenues
 
4,558

 
4,825

 
4,886

 
4,875

 
4,851

 
 
18,528

 
19,437

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted expenses
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Policyholder benefits and claims and policyholder dividends
 
3,577

 
3,711

 
3,812

 
3,724

 
3,685

 
 
14,435

 
14,932

 
 
Interest credited to policyholder account balances
 
39

 
39

 
39

 
42

 
37

 
 
145

 
157

 
 
Capitalization of DAC
 
(6
)
 
(8
)
 
(6
)
 
(9
)
 
(5
)
 
 
(27
)
 
(28
)
 
 
Amortization of DAC and VOBA
 
10

 
9

 
8

 
8

 
10

 
 
53

 
35

 
 
Amortization of negative VOBA
 

 

 

 

 

 
 

 

 
 
Interest expense on debt
 
1

 

 
1

 

 

 
 
2

 
1

 
 
Other expenses
 
640

 
641

 
639

 
646

 
708

 
 
2,531

 
2,634

 
 
Total adjusted expenses
 
4,261

 
4,392

 
4,493

 
4,411

 
4,435

 
 
17,139

 
17,731

 
 
Adjusted earnings before provision for income tax
 
297

 
433

 
393

 
464

 
416

 
 
1,389

 
1,706

 
 
Provision for income tax expense (benefit)
 
67

 
91

 
82

 
98

 
87

 
 
310

 
358

 
 
Adjusted earnings
 
230

 
342

 
311

 
366

 
329

 
 
1,079

 
1,348

 
 
Preferred stock dividends
 

 

 

 

 

 
 

 

 
 
Adjusted earnings available to common shareholders
 
$
230

 
$
342

 
$
311

 
$
366

 
$
329

 
 
$
1,079

 
$
1,348

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted premiums, fees and other revenues
 
$
4,283

 
$
4,545

 
$
4,594

 
$
4,582

 
$
4,554

 
 
$
17,401

 
$
18,275

 

12


 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
U.S.
RETIREMENT AND INCOME SOLUTIONS
STATEMENTS OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS
 
 
 
For the Three Months Ended
 
For the Year Ended
 
Unaudited (In millions)
 
December 31, 2018

 
March 31, 2019

 
June 30, 2019

 
September 30, 2019

 
December 31, 2019

 
 
December 31, 2018

 
December 31, 2019

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted revenues
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Premiums
 
$
373

 
$
461

 
$
1,075

 
$
1,739

 
$
2,955

 
 
$
8,511

 
$
6,230

 
 
Universal life and investment-type product policy fees
 
79

 
76

 
71

 
66

 
76

 
 
249

 
289

 
 
Net investment income
 
1,492

 
1,395

 
1,458

 
1,419

 
1,409

 
 
5,676

 
5,681

 
 
Other revenues
 
71

 
72

 
74

 
73

 
73

 
 
284

 
292

 
 
Total adjusted revenues
 
2,015

 
2,004

 
2,678

 
3,297

 
4,513

 
 
14,720

 
12,492

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted expenses
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Policyholder benefits and claims and policyholder dividends
 
998

 
1,071

 
1,647

 
2,361

 
3,550

 
 
10,886

 
8,629

 
 
Interest credited to policyholder account balances
 
448

 
462

 
465

 
465

 
435

 
 
1,645

 
1,827

 
 
Capitalization of DAC
 
(7
)
 
(8
)
 
(12
)
 
(5
)
 

 
 
(15
)
 
(25
)
 
 
Amortization of DAC and VOBA
 
7

 
5

 
7

 
5

 
6

 
 
24

 
23

 
 
Amortization of negative VOBA
 

 

 

 

 

 
 

 

 
 
Interest expense on debt
 
3

 
2

 
2

 
3

 
2

 
 
10

 
9

 
 
Other expenses
 
116

 
114

 
127

 
111

 
116

 
 
432

 
468

 
 
Total adjusted expenses
 
1,565

 
1,646

 
2,236

 
2,940

 
4,109

 
 
12,982

 
10,931

 
 
Adjusted earnings before provision for income tax
 
450

 
358

 
442

 
357

 
404

 
 
1,738

 
1,561

 
 
Provision for income tax expense (benefit)
 
94

 
73

 
91

 
73

 
83

 
 
357

 
320

 
 
Adjusted earnings
 
356

 
285

 
351

 
284

 
321

 
 
1,381

 
1,241

 
 
Preferred stock dividends
 

 

 

 

 

 
 

 

 
 
Adjusted earnings available to common shareholders
 
$
356

 
$
285

 
$
351

 
$
284

 
$
321

 
 
$
1,381

 
$
1,241

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted premiums, fees and other revenues
 
$
523

 
$
609

 
$
1,220

 
$
1,878

 
$
3,104

 
 
$
9,044

 
$
6,811

 
 
Less: PRT
 
(76
)
 
(2
)
 
556

 
1,293

 
2,499

 
 
6,894

 
4,346

 
 
Adjusted premiums, fees and other revenues, excluding PRT
 
$
599

 
$
611

 
$
664

 
$
585

 
$
605

 
 
$
2,150

 
$
2,465

 

13


 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
U.S.
PROPERTY & CASUALTY
STATEMENTS OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS
 
 
  
 
For the Three Months Ended
 
 
For the Year Ended
 
Unaudited (In millions)
 
December 31, 2018

 
March 31, 2019

 
June 30, 2019

 
September 30, 2019

 
December 31, 2019

 
 
December 31, 2018

 
December 31, 2019

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted revenues
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Premiums
 
$
914

 
$
898

 
$
912

 
$
925

 
$
925

 
 
$
3,593

 
$
3,660

 
 
Universal life and investment-type product policy fees
 

 

 

 

 

 
 

 

 
 
Net investment income
 
42

 
44

 
45

 
48

 
41

 
 
174

 
178

 
 
Other revenues
 
5

 
6

 
5

 
6

 
3

 
 
22

 
20

 
 
Total adjusted revenues
 
961

 
948

 
962

 
979

 
969

 
 
3,789

 
3,858

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted expenses
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Policyholder benefits and claims and policyholder dividends
 
600

 
591

 
642

 
674

 
697

 
 
2,444

 
2,604

 
 
Interest credited to policyholder account balances
 

 

 

 

 

 
 

 

 
 
Capitalization of DAC
 
(100
)
 
(98
)
 
(109
)
 
(117
)
 
(107
)
 
 
(407
)
 
(431
)
 
 
Amortization of DAC and VOBA
 
103

 
100

 
102

 
108

 
107

 
 
400

 
417

 
 
Amortization of negative VOBA
 

 

 

 

 

 
 

 

 
 
Interest expense on debt
 

 

 

 

 

 
 

 

 
 
Other expenses
 
238

 
238

 
243

 
247

 
245

 
 
939

 
973

 
 
Total adjusted expenses
 
841

 
831

 
878

 
912

 
942

 
 
3,376

 
3,563

 
 
Adjusted earnings before provision for income tax
 
120

 
117

 
84

 
67

 
27

 
 
413

 
295

 
 
Provision for income tax expense (benefit)
 
21

 
20

 
14

 
10

 
2

 
 
69

 
46

 
 
Adjusted earnings
 
99

 
97

 
70

 
57

 
25

 
 
344

 
249

 
 
Preferred stock dividends
 

 

 

 

 

 
 

 

 
 
Adjusted earnings available to common shareholders
 
$
99

 
$
97

 
$
70

 
$
57

 
$
25

 
 
$
344

 
$
249

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted premiums, fees and other revenues
 
$
919

 
$
904

 
$
917

 
$
931

 
$
928

 
 
$
3,615

 
$
3,680

 

14


 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
U.S.
GROUP BENEFITS
 
 
FUTURE POLICY BENEFITS AND POLICYHOLDER ACCOUNT BALANCES
 
 
 
 
 
 
 
  
 
For the Three Months Ended
 
 
Unaudited (In millions)
 
December 31, 2018

 
March 31, 2019

 
June 30, 2019

 
September 30, 2019

 
 
December 31, 2019

 
 
Balance, beginning of period
 
$
18,904

 
$
18,924

 
$
18,926

 
$
18,965

 
 
$
18,963

 
 
Premiums and deposits
 
4,764

 
5,019

 
5,081

 
5,051

 
 
5,001

 
 
Surrenders and withdrawals
 
(599
)
 
(597
)
 
(619
)
 
(638
)
 
 
(592
)
 
 
Benefit payments
 
(3,691
)
 
(3,836
)
 
(3,887
)
 
(3,798
)
 
 
(3,757
)
 
 
Net flows
 
474

 
586

 
575

 
615

 
 
652

 
 
Net transfers from (to) separate account
 
(1
)
 
1

 

 

 
 

 
 
Interest
 
147

 
145

 
152

 
149

 
 
145

 
 
Policy charges
 
(147
)
 
(147
)
 
(150
)
 
(145
)
 
 
(149
)
 
 
Other
 
(453
)
 
(583
)
 
(538
)
 
(621
)
 
 
(646
)
 
 
Balance, end of period
 
$
18,924

 
$
18,926

 
$
18,965

 
$
18,963

 
 
$
18,965

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SEPARATE ACCOUNT LIABILITIES
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
For the Three Months Ended
 
 
Unaudited (In millions)
 
December 31, 2018

 
March 31, 2019

 
June 30, 2019

 
September 30, 2019

 
 
December 31, 2019

 
 
Balance, beginning of period
 
$
935

 
$
813

 
$
902

 
$
925

 
 
$
905

 
 
Premiums and deposits
 
64

 
64

 
64

 
62

 
 
65

 
 
Surrenders and withdrawals
 
(14
)
 
(18
)
 
(18
)
 
(28
)
 
 
(18
)
 
 
Benefit payments
 
(1
)
 
(1
)
 
(1
)
 
(1
)
 
 
(1
)
 
 
Net flows
 
49

 
45

 
45

 
33

 
 
46

 
 
Investment performance
 
(117
)
 
101

 
34

 
1

 
 
74

 
 
Net transfers from (to) general account
 
1

 
(1
)
 

 

 
 

 
 
Policy charges
 
(52
)
 
(53
)
 
(54
)
 
(53
)
 
 
(54
)
 
 
Other
 
(3
)
 
(3
)
 
(2
)
 
(1
)
 
 
(1
)
 
 
Balance, end of period
 
$
813

 
$
902

 
$
925

 
$
905

 
 
$
970

 

15


 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
U.S.
GROUP BENEFITS
 
 
OTHER EXPENSES BY MAJOR CATEGORY
 
 
 
 
 
 
 
 
 
  
 
For the Three Months Ended
 
 
Unaudited (In millions)
 
December 31, 2018

 
 
March 31, 2019

 
 
June 30, 2019

 
 
September 30, 2019

 
December 31, 2019

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Direct and allocated expenses
 
$
319

 
 
$
310

 
 
$
314

 
 
$
316

 
$
363

 
 
Pension, postretirement and postemployment benefit costs
 
8

 
 
15

 
 
15

 
 
15

 
19

 
 
Premium taxes, other taxes, and licenses & fees
 
83

 
 
63

 
 
67

 
 
62

 
66

 
 
Commissions and other variable expenses
 
230

 
 
253

 
 
243

 
 
253

 
260

 
 
Other expenses, as reported on an adjusted basis
 
$
640

 
 
$
641

 
 
$
639

 
 
$
646

 
$
708

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
OTHER STATISTICAL INFORMATION 
 
 
 
 
 
 
 
  
 
For the Three Months Ended
 
 
Unaudited (In millions, except ratios)
 
December 31, 2018

 
 
March 31, 2019

 
 
June 30, 2019

 
 
September 30, 2019

 
December 31, 2019

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Group Life (1)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted premiums, fees and other revenues
 
$
1,688

 
 
$
1,804

 
 
$
1,805

 
 
$
1,846

 
$
1,858

 
 
Mortality ratio
 
89.4
%
 
 
85.3
%
 
 
85.3
%
 
 
87.0
%
 
85.4
%
 
 
Group Non-Medical Health (2)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted premiums, fees and other revenues
 
$
1,742

 
 
$
1,812

 
 
$
1,820

 
 
$
1,830

 
$
1,849

 
 
Interest adjusted benefit ratio (3)
 
73.2
%
 
 
72.9
%
 
 
75.4
%
 
 
70.3
%
 
71.4
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(1) Excludes certain experience-rated contracts and includes accidental death and dismemberment.
 
 
(2) Includes dental, group and individual disability, accident & health, critical illness, vision and other health.
 
 
(3) Reflects actual claims experience and excludes the impact of interest credited on future policyholder benefits. The product within Group Non-Medical Health with interest credited on future policyholder benefits is disability.
 


16


 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
U.S.
RETIREMENT AND INCOME SOLUTIONS
 
 
 
FUTURE POLICY BENEFITS AND POLICYHOLDER ACCOUNT BALANCES
 
 
 
 
 
 
 
  
 
For the Three Months Ended
 
 
Unaudited (In millions)
 
December 31, 2018

 
March 31, 2019

 
June 30, 2019

 
September 30, 2019

 
 
December 31, 2019

 
 
Balance, beginning of period
 
$
114,796

 
$
113,653

 
$
115,419

 
$
118,073

 
 
$
118,134

 
 
Premiums and deposits
 
15,711

 
19,068

 
17,898

 
21,104

 
 
21,132

 
 
Surrenders and withdrawals
 
(17,014
)
 
(17,356
)
 
(16,582
)
 
(21,018
)
 
 
(17,718
)
 
 
Benefit payments
 
(998
)
 
(1,035
)
 
(1,021
)
 
(1,100
)
 
 
(1,040
)
 
 
Net flows
 
(2,301
)
 
677

 
295

 
(1,014
)
 
 
2,374

 
 
Net transfers from (to) separate account
 

 

 

 

 
 

 
 
Interest
 
1,040

 
1,052

 
1,051

 
1,053

 
 
1,029

 
 
Policy charges
 
(10
)
 
(32
)
 
(46
)
 
(47
)
 
 
(23
)
 
 
Other
 
128

 
69

 
1,354

 
69

 
 
339

 
 
Balance, end of period
 
$
113,653

 
$
115,419

 
$
118,073

 
$
118,134

 
 
$
121,853

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SEPARATE ACCOUNT LIABILITIES
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
For the Three Months Ended
 
 
Unaudited (In millions)
 
December 31, 2018


March 31, 2019


June 30, 2019


September 30, 2019



December 31, 2019

 
 
Balance, beginning of period
 
$
70,396

 
$
70,623

 
$
73,691

 
$
76,596

 
 
$
78,346

 
 
Premiums and deposits
 
2,355

 
1,088

 
1,469

 
1,472

 
 
1,681

 
 
Surrenders and withdrawals (1)
 
(2,276
)
 
(1,164
)
 
(1,780
)
 
(1,461
)
 
 
(4,360
)
 
 
Benefit payments
 
(18
)
 
(16
)
 
(29
)
 
(21
)
 
 
(27
)
 
 
Net flows
 
61

 
(92
)
 
(340
)
 
(10
)
 
 
(2,706
)
 
 
Investment performance
 
(542
)
 
2,741

 
2,184

 
1,508

 
 
865

 
 
Net transfers from (to) general account
 

 

 

 

 
 

 
 
Policy charges
 
(93
)
 
(64
)
 
(75
)
 
(83
)
 
 
(85
)
 
 
Other
 
801

 
483

 
1,136

 
335

 
 
(1,461
)
 
 
Balance, end of period
 
$
70,623

 
$
73,691

 
$
76,596

 
$
78,346

 
 
$
74,959

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SYNTHETIC GICS (2)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For the Three Months Ended
 
 
Unaudited (In millions)
 
December 31, 2018

 
March 31, 2019

 
June 30, 2019

 
September 30, 2019

 
 
December 31, 2019

 
 
Balance, beginning of period
 
$
24,244

 
$
25,700

 
$
26,501

 
$
27,219

 
 
$
28,098

 
 
Premiums and deposits (1)
 
1,518

 
776

 
770

 
1,054

 
 
3,019

 
 
Surrenders and withdrawals
 
(232
)
 
(150
)
 
(236
)
 
(369
)
 
 
(985
)
 
 
Net flows
 
1,286

 
626

 
534

 
685

 
 
2,034

 
 
Interest
 
170

 
175

 
184

 
194

 
 
209

 
 
Balance, end of period
 
$
25,700

 
$
26,501

 
$
27,219

 
$
28,098

 
 
$
30,341

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(1) Includes $930 million, $0, $102 million, $20 million and $2.4 billion of transfers from separate account GICs to synthetic GICs at December 31, 2018, March 31, 2019, June 30, 2019, September 30, 2019 and December 31, 2019, respectively. These transfers are reported as surrenders and withdrawals on the separate account liabilities table and premiums and deposits on the synthetic GICs table.
 
(2) A synthetic GIC is a contract that simulates the performance of a traditional GIC through the use of financial instruments and is reported as a derivative. A key difference between a synthetic GIC and a traditional GIC is that the contractholder owns the assets underlying the synthetic GIC. The assets and corresponding contractholder account balance are not on MetLife, Inc.'s consolidated balance sheet, as they are for a traditional GIC. The contractholder account balance is reported at contract value in the table above.


17


 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
U.S.
RETIREMENT AND INCOME SOLUTIONS
 
 
OTHER EXPENSES BY MAJOR CATEGORY
 
 
 
 
 
 
 
 
 
 
 
For the Three Months Ended
 
 
Unaudited (In millions)
 
December 31, 2018

 
 
March 31, 2019

 
 
June 30, 2019

 
 
September 30, 2019

 
 
December 31, 2019

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Direct and allocated expenses
 
$
63

 
 
$
62

 
 
$
64

 
 
$
56

 
 
$
61

 
 
Pension, postretirement and postemployment benefit costs
 
1

 
 
3

 
 
3

 
 
2

 
 
3

 
 
Premium taxes, other taxes, and licenses & fees
 
11

 
 
5

 
 
9

 
 
4

 
 
12

 
 
Commissions and other variable expenses
 
41

 
 
44

 
 
51

 
 
49

 
 
40

 
 
Other expenses, as reported on an adjusted basis
 
$
116

 
 
$
114

 
 
$
127

 
 
$
111

 
 
$
116

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SPREAD
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For the Three Months Ended
 
 
Unaudited
 
December 31, 2018

 
 
March 31, 2019

 
 
June 30, 2019

 
 
September 30, 2019

 
 
December 31, 2019

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investment income yield excluding variable investment income yield
 
4.80
%
 
 
4.52
%
 
 
4.50
%
 
 
4.43
%
 
 
4.32
%
 
 
Variable investment income yield
 
0.27
%
 
 
0.15
%
 
 
0.35
%
 
 
0.23
%
 
 
0.23
%
 
 
Total investment income yield
 
5.07
%
 
 
4.67
%
 
 
4.85
%
 
 
4.66
%
 
 
4.55
%
 
 
Average crediting rate
 
3.77
%
 
 
3.71
%
 
 
3.66
%
 
 
3.64
%
 
 
3.49
%
 
 
Annualized general account spread
 
1.30
%
 
 
0.96
%
 
 
1.19
%
 
 
1.02
%
 
 
1.06
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Annualized general account spread excluding variable investment income yield
 
1.03
%
 
 
0.81
%
 
 
0.84
%
 
 
0.79
%
 
 
0.83
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 


18


 
U.S.
PROPERTY & CASUALTY
 
 
OTHER EXPENSES BY MAJOR CATEGORY
 
 
 
 
 
 
 
  
 
For the Three Months Ended
 
 
Unaudited (In millions)
 
December 31, 2018
 
March 31, 2019
 
June 30, 2019
 
September 30, 2019
 
 
December 31, 2019
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Direct and allocated expenses
 
$
109

 
$
105

 
$
100

 
$
101

 
 
$
105

 
 
Pension, postretirement and postemployment benefit costs
 
3

 
2

 
2

 
2

 
 
3

 
 
Premium taxes, other taxes, and licenses & fees
 
24

 
22

 
27

 
24

 
 
23

 
 
Commissions and other variable expenses
 
102

 
109

 
114

 
120

 
 
114

 
 
Other expenses, as reported on an adjusted basis
 
$
238

 
$
238

 
$
243

 
$
247

 
 
$
245

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NET WRITTEN PREMIUMS BY PRODUCT AND SELECTED FINANCIAL INFORMATION AND SUPPLEMENTAL DATA
 
 
 
 
For the Three Months Ended
 
 
Unaudited (In millions, except ratios)
 
December 31, 2018
 
March 31, 2019
 
June 30, 2019
 
September 30, 2019
 
 
December 31, 2019
 
 

 
 
 
 
 
 
 
 
 
 
 
 
 
Net Written Premiums by Product
 
 
 
 
 
 
 
 
 
 
 
 
 
Auto
 
$
588

 
$
588

 
$
615

 
$
623

 
 
$
576

 
 
Homeowners & Other
 
307

 
277

 
347

 
354

 
 
321

 
 
Total
 
$
895

 
$
865

 
$
962

 
$
977

 
 
$
897

 
 
Selected Financial Information and Supplemental Data (1)
 
 
 
 
 
 
 
 
 
 
 
 
 
Total Property & Casualty
 
 
 
 
 
 
 
 
 
 
 
 
 
Net earned premium
 
$
914

 
$
898

 
$
912

 
$
925

 
 
$
925

 
 
Loss and loss adjustment expense ratio
 
65.6
 %
 
65.5
 %
 
70.4
 %
 
72.9
 %
 
 
75.3
 %
 
 
Other expense ratio
 
26.2
 %
 
26.7
 %
 
25.7
 %
 
25.5
 %
 
 
26.3
 %
 
 
Total combined ratio
 
91.8
 %
 
92.2
 %
 
96.1
 %
 
98.4
 %
 
 
101.6
 %
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Effect of catastrophe losses
 
2.7
 %
 
4.6
 %
 
8.6
 %
 
7.6
 %
 
 
1.4
 %
 
 
Combined ratio excluding catastrophes
 
89.1
 %
 
87.6
 %
 
87.5
 %
 
90.8
 %
 
 
100.2
 %
 
 
Prior year development
 
(0.6)
 %
 
(0.3)
 %
 
(0.6)
 %
 
(0.6)
 %
 
 
6.3
 %
 
 
Combined ratio excluding catastrophes and prior year development before provision for income tax
 
89.7
 %
 
87.9
 %
 
88.1
 %
 
91.4
 %
 
 
93.9
 %
 
 
Auto
 
 
 
 
 
 
 
 
 
 
 
 
 
Net earned premium
 
$
603

 
$
591

 
$
598

 
$
603

 
 
$
599

 
 
Loss and loss adjustment expense ratio
 
74.0
 %
 
67.7
 %
 
67.8
 %
 
73.8
 %
 
 
92.8
 %
 
 
Other expense ratio
 
25.5
 %
 
26.6
 %
 
25.2
 %
 
24.9
 %
 
 
25.8
 %
 
 
Total combined ratio
 
99.5
 %
 
94.3
 %
 
93.0
 %
 
98.7
 %
 
 
118.6
 %
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Effect of catastrophe losses
 
 %
 
0.4
 %
 
1.7
 %
 
2.1
 %
 
 
0.3
 %
 
 
Combined ratio excluding catastrophes
 
99.5
 %
 
93.9
 %
 
91.3
 %
 
96.6
 %
 
 
118.3
 %
 
 
Prior year development
 
(0.1)
 %
 
(0.4
)%
 
(0.7
)%
 
(0.8)
 %
 
 
10.9
 %
 
 
Combined ratio excluding catastrophes and prior year development before provision for income tax
 
99.6
 %
 
94.3
 %
 
92.0
 %
 
97.4
 %
 
 
107.4
 %
 
 
Homeowners & Other
 
 
 
 
 
 
 
 
 
 
 
 
 
Net earned premium
 
$
311

 
$
307

 
$
314

 
$
322

 
 
$
326

 
 
Loss and loss adjustment expense ratio
 
49.4
 %
 
61.3
 %
 
75.4
 %
 
71.2
 %
 
 
43.2
 %
 
 
Other expense ratio
 
27.5
 %
 
27.0
 %
 
26.7
 %
 
26.6
 %
 
 
27.1
 %
 
 
Total combined ratio
 
76.9
 %
 
88.3
 %
 
102.1
 %
 
97.8
 %
 
 
70.3
 %
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Effect of catastrophe losses
 
8.0
 %
 
12.5
 %
 
21.6
 %
 
17.9
 %
 
 
3.5
 %
 
 
Combined ratio excluding catastrophes
 
68.9
 %
 
75.8
 %
 
80.5
 %
 
79.9
 %
 
 
66.8
 %
 
 
Prior year development
 
(1.5)
 %
 
(0.1)
 %
 
(0.2)
 %
 
(0.3)
 %
 
 
(2.0)
 %
 
 
Combined ratio excluding catastrophes and prior year development before provision for income tax
 
70.4
 %
 
75.9
 %
 
80.7
 %
 
80.2
 %
 
 
68.8
 %
 
 
Catastrophe Losses Before Provision for Income Tax
 
 
 
 
 
 
 
 
 
 
 
 
 
Auto
 
$

 
$
2

 
$
10

 
$
13

 
 
$
2

 
 
Homeowners & Other
 
25

 
39

 
68

 
57

 
 
11

 
 
Total
 
$
25

 
$
41

 
$
78

 
$
70

 
 
$
13

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(1) This selected financial information and supplemental data are presented and calculated based on general industry standards.
 

19


 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ASIA
STATEMENTS OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS 
 
 
 
For the Three Months Ended
 
For the Year Ended
 
Unaudited (In millions)
 
December 31, 2018

 
March 31, 2019

 
June 30, 2019

 
September 30, 2019

 
December 31, 2019

 
 
December 31, 2018

 
December 31, 2019

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted revenues
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Premiums
 
$
1,675

 
$
1,699

 
$
1,631

 
$
1,654

 
$
1,648

 
 
$
6,766

 
$
6,632

 
 
Universal life and investment-type product policy fees
 
409

 
406

 
419

 
430

 
419

 
 
1,630

 
1,674

 
 
Net investment income
 
853

 
880

 
944

 
915

 
952

 
 
3,317

 
3,691

 
 
Other revenues
 
11

 
16

 
13

 
14

 
13

 
 
51

 
56

 
 
Total adjusted revenues
 
2,948

 
3,001

 
3,007

 
3,013

 
3,032

 
 
11,764

 
12,053

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted expenses
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Policyholder benefits and claims and policyholder dividends
 
1,392

 
1,319

 
1,279

 
1,264

 
1,323

 
 
5,326

 
5,185

 
 
Interest credited to policyholder account balances
 
371

 
403

 
424

 
440

 
443

 
 
1,465

 
1,710

 
 
Capitalization of DAC
 
(477
)
 
(479
)
 
(472
)
 
(498
)
 
(464
)
 
 
(1,915
)
 
(1,913
)
 
 
Amortization of DAC and VOBA
 
309

 
307

 
312

 
353

 
316

 
 
1,302

 
1,288

 
 
Amortization of negative VOBA
 
(8
)
 
(9
)
 
(7
)
 
(2
)
 
(7
)
 
 
(39
)
 
(25
)
 
 
Interest expense on debt
 

 

 

 

 

 
 

 

 
 
Other expenses
 
969

 
955

 
955

 
955

 
953

 
 
3,840

 
3,818

 
 
Total adjusted expenses
 
2,556

 
2,496

 
2,491

 
2,512

 
2,564

 
 
9,979

 
10,063

 
 
Adjusted earnings before provision for income tax
 
392

 
505

 
516

 
501

 
468

 
 
1,785

 
1,990

 
 
Provision for income tax expense (benefit)
 
111

 
149

 
157

 
152

 
127

 
 
548

 
585

 
 
Adjusted earnings
 
281

 
356

 
359

 
349

 
341

 
 
1,237

 
1,405

 
 
Preferred stock dividends
 

 

 

 

 

 
 

 

 
 
Adjusted earnings available to common shareholders
 
$
281

 
$
356

 
$
359

 
$
349

 
$
341

 
 
$
1,237

 
$
1,405

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted premiums, fees and other revenues
 
$
2,095

 
$
2,121

 
$
2,063

 
$
2,098

 
$
2,080

 
 
$
8,447

 
$
8,362

 

20


 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ASIA
 
 
ADJUSTED PREMIUMS, FEES AND OTHER REVENUES
 
 
 
 
For the Three Months Ended
 
 
Unaudited (In millions)
 
December 31, 2018
 
 
March 31, 2019
 
 
June 30, 2019
 
 
September 30, 2019
 
 
December 31, 2019
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted premiums, fees and other revenues
 
$
2,095

 
 
$
2,121

 
 
$
2,063

 
 
$
2,098

 
 
$
2,080

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted premiums, fees and other revenues, on a constant currency basis
 
$
2,128

 
 
$
2,119

 
 
$
2,073

 
 
$
2,083

 
 
$
2,080

 
 
Add: Operating joint ventures, on a constant currency basis (1), (2)
 
248

 
 
241

 
 
276

 
 
249

 
 
279

 
 
Adjusted premiums, fees and other revenues, including operating joint ventures, on a constant currency basis
 
$
2,376

 
 
$
2,360

 
 
$
2,349

 
 
$
2,332

 
 
$
2,359

 
 
 
 
 
OTHER EXPENSES BY MAJOR CATEGORY
 
 
 
 
For the Three Months Ended
 
 
Unaudited (In millions)
 
December 31, 2018
 
 
March 31, 2019
 
 
June 30, 2019
 
 
September 30, 2019
 
 
December 31, 2019
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Direct and allocated expenses
 
$
336

 
 
$
324

 
 
$
332

 
 
$
316

 
 
$
343

 
 
Pension, postretirement and postemployment benefit costs
 
22

 
 
23

 
 
23

 
 
23

 
 
23

 
 
Premium taxes, other taxes, and licenses & fees
 
44

 
 
43

 
 
43

 
 
43

 
 
51

 
 
Commissions and other variable expenses
 
567

 
 
565

 
 
557

 
 
573

 
 
536

 
 
Other expenses, as reported on an adjusted basis
 
$
969

 
 
$
955

 
 
$
955

 
 
$
955

 
 
$
953

 
 
Other expenses, as reported on an adjusted basis, net of capitalization of DAC
 
$
492

 
 
$
476

 
 
$
483

 
 
$
457

 
 
$
489

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Other expenses, as reported on an adjusted basis, on a constant currency basis
 
$
987

 
 
$
957

 
 
$
959

 
 
$
948

 
 
$
953

 
 
Add: Operating joint ventures, on a constant currency basis (1), (2)
 
106

 
 
103

 
 
106

 
 
103

 
 
111

 
 
Other expenses, as reported on an adjusted basis, including operating joint ventures, on a constant currency basis
 
$
1,093

 
 
$
1,060

 
 
$
1,065

 
 
$
1,051

 
 
$
1,064

 
 
Other expenses, as reported on an adjusted basis, including operating joint ventures, net of capitalization of DAC, on a constant currency basis
 
$
564

 
 
$
541

 
 
$
554

 
 
$
522

 
 
$
565

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SALES ON A CONSTANT CURRENCY BASIS
 
 
 
 
For the Three Months Ended
 
 
Unaudited (In millions)
 
December 31, 2018
 
 
March 31, 2019
 
 
June 30, 2019
 
 
September 30, 2019
 
 
December 31, 2019
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Japan:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Life
 
$
184

 
 
$
174

 
 
$
163

 
 
$
169

 
 
$
156

 
 
Accident & Health
 
102

 
 
114

 
 
104

 
 
90

 
 
92

 
 
Annuities
 
125

 
 
178

 
 
135

 
 
122

 
 
65

 
 
Other
 
2

 
 
1

 
 
2

 
 
4

 
 
5

 
 
Total Japan
 
413

 
 
467

 
 
404

 
 
385

 
 
318

 
 
Other Asia
 
214

 
 
224

 
 
199

 
 
274

 
 
207

 
 
   Total sales
 
$
627

 
 
$
691

 
 
$
603

 
 
$
659

 
 
$
525

 
 
 
 
 
OTHER STATISTICAL INFORMATION
 
 
 
 
 
 
For the Three Months Ended
 
 
Unaudited (In millions)
 
December 31, 2018
 
 
March 31, 2019
 
 
June 30, 2019
 
 
September 30, 2019
 
 
December 31, 2019
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted earnings available to common shareholders
 
$
281

 
 
$
356

 
 
$
359

 
 
$
349

 
 
$
341

 
 
Adjusted earnings available to common shareholders, on a constant currency basis
 
$
278

 
 
$
351

 
 
$
357

 
 
$
350

 
 
$
341

 
 
 
 
(1) Adjusted premiums, fees and other revenues as well as other expenses are reported as part of net investment income on the statement of adjusted earnings available to common shareholders for operating joint ventures.
 
(2) Includes MetLife, Inc.'s percentage interest in operating joint ventures of: (i) China, (ii) India, (iii) Malaysia and (iv) Vietnam, which are consolidated using the equity method of accounting.


21


 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ASIA
 
 
 
 
 
GENERAL ACCOUNT ASSETS UNDER MANAGEMENT AND RELATED MEASURES
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Unaudited (In millions)
 
December 31, 2018
 
March 31, 2019
 
June 30, 2019
 
September 30, 2019
 
 
December 31, 2019
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total investments
 
$
115,433

 
$
121,224

 
$
127,178

 
$
130,734

 
 
$
130,482

 
 
 Add:
 
 
 
 
 
 
 
 
 
 
 
 
 
  Cash and cash equivalents
 
3,126

 
3,264

 
3,406

 
3,239

 
 
2,508

 
 
  FVA - mortgage loans
 
(47
)
 
203

 
359

 
446

 
 
377

 
 
  FVA - real estate and real estate joint ventures
 
529

 
533

 
694

 
703

 
 
704

 
 
 Less:
 
 
 
 
 
 
 
 
 
 
 
 
 
  Policy loans
 
1,654

 
1,644

 
1,656

 
1,643

 
 
1,658

 
 
  Other invested assets (including operating joint ventures)
 
334

 
59

 
26

 
40

 
 
(615
)
 
 
  Contractholder-directed equity securities and fair value option securities
 
2,096

 
2,148

 
2,146

 
2,130

 
 
2,167

 
 
GA AUM
 
114,957

 
121,373

 
127,809

 
131,309

 
 
130,861

 
 
Less:
 
 
 
 
 
 
 
 
 
 
 
 
 
  Unrealized gains (losses) on investments carried at estimated fair value
 
5,745

 
8,417

 
10,747

 
12,243

 
 
10,736

 
 
  FVA - mortgage loans
 
(47
)
 
203

 
359

 
446

 
 
377

 
 
  FVA - real estate and real estate joint ventures
 
529

 
533

 
694

 
703

 
 
704

 
 
GA AUM (excluding FVA)
 
$
108,730

 
$
112,220

 
$
116,009

 
$
117,917

 
 
$
119,044

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
GA AUM (excluding FVA), on a constant currency basis
 
$
108,934

 
$
112,876

 
$
115,553

 
$
118,546

 
 
$
119,044

 
 
  Add: Operating joint ventures, on a constant currency basis (1)
 
3,848

 
4,021

 
4,188

 
4,363

 
 
4,620

 
 
GA AUM (excluding FVA), including operating joint ventures, on a constant currency basis
 
$
112,782

 
$
116,897

 
$
119,741

 
$
122,909

 
 
$
123,664

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(1) Includes MetLife, Inc.'s percentage interest in operating joint ventures of: (i) China, (ii) India, (iii) Malaysia and (iv) Vietnam, which are consolidated using the equity method of accounting and reported in other invested assets, a component of total investments.


22


 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LATIN AMERICA
STATEMENTS OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS
 
 
 
 
For the Three Months Ended
 
For the Year Ended
 
Unaudited (In millions)
 
December 31, 2018

 
March 31, 2019

 
June 30, 2019

 
September 30, 2019

 
December 31, 2019

 
 
December 31, 2018

 
December 31, 2019

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted revenues
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Premiums
 
$
681

 
$
646

 
$
773

 
$
703

 
$
601

 
 
$
2,760

 
$
2,723

 
 
Universal life and investment-type product policy fees
 
264

 
284

 
280

 
256

 
274

 
 
1,050

 
1,094

 
 
Net investment income
 
297

 
296

 
360

 
295

 
320

 
 
1,239

 
1,271

 
 
Other revenues
 
11

 
12

 
11

 
8

 
13

 
 
35

 
44

 
 
Total adjusted revenues
 
1,253

 
1,238

 
1,424

 
1,262

 
1,208

 
 
5,084

 
5,132

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted expenses
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Policyholder benefits and claims and policyholder dividends
 
626

 
597

 
790

 
656

 
580

 
 
2,602

 
2,623

 
 
Interest credited to policyholder account balances
 
99

 
94

 
86

 
74

 
78

 
 
394

 
332

 
 
Capitalization of DAC
 
(95
)
 
(94
)
 
(100
)
 
(102
)
 
(100
)
 
 
(377
)
 
(396
)
 
 
Amortization of DAC and VOBA
 
73

 
78

 
79

 
58

 
76

 
 
209

 
291

 
 
Amortization of negative VOBA
 

 

 

 

 

 
 
(1
)
 

 
 
Interest expense on debt
 
1

 
1

 
1

 

 
1

 
 
6

 
3

 
 
Other expenses
 
369

 
366

 
352

 
356

 
369

 
 
1,421

 
1,443

 
 
Total adjusted expenses
 
1,073

 
1,042

 
1,208

 
1,042

 
1,004

 
 
4,254

 
4,296

 
 
Adjusted earnings before provision for income tax
 
180

 
196

 
216

 
220

 
204

 
 
830

 
836

 
 
Provision for income tax expense (benefit)
 
43

 
62

 
57

 
65

 
43

 
 
238

 
227

 
 
Adjusted earnings
 
137

 
134

 
159

 
155

 
161

 
 
592

 
609

 
 
Preferred stock dividends
 

 

 

 

 

 
 

 

 
 
Adjusted earnings available to common shareholders
 
$
137

 
$
134

 
$
159

 
$
155

 
$
161

 
 
$
592

 
$
609

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted premiums, fees and other revenues
 
$
956

 
$
942

 
$
1,064

 
$
967

 
$
888

 
 
$
3,845

 
$
3,861

 

23


 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LATIN AMERICA
 
 
OTHER EXPENSES BY MAJOR CATEGORY
 
 
 
 
 
 
 
 
 
 
 
For the Three Months Ended
 
 
Unaudited (In millions)
 
December 31, 2018

 
 
March 31, 2019

 
 
June 30, 2019

 
 
September 30, 2019

 
 
December 31, 2019

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Direct and allocated expenses
 
$
148

 
 
$
148

 
 
$
134

 
 
$
130

 
 
$
145

 
 
Pension, postretirement and postemployment benefit costs
 
1

 
 
1

 
 
1

 
 
1

 
 
2

 
 
Premium taxes, other taxes, and licenses & fees
 
18

 
 
15

 
 
14

 
 
15

 
 
14

 
 
Commissions and other variable expenses
 
202

 
 
202

 
 
203

 
 
210

 
 
208

 
 
Other expenses, as reported on an adjusted basis
 
$
369

 
 
$
366

 
 
$
352

 
 
$
356

 
 
$
369

 
 
Other expenses, as reported on an adjusted basis, net of capitalization of DAC
 
$
274

 
 
$
272

 
 
$
252

 
 
$
254

 
 
$
269

 
 
Other expenses, as reported on an adjusted basis, on a constant currency basis
 
$
359

 
 
$
348

 
 
$
338

 
 
$
349

 
 
$
369

 
 
Other expenses, as reported on an adjusted basis, net of capitalization of DAC, on a constant currency basis
 
$
266

 
 
$
258

 
 
$
242

 
 
$
249

 
 
$
269

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SALES ON A CONSTANT CURRENCY BASIS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For the Three Months Ended
 
 
Unaudited (In millions)
 
December 31, 2018

 
 
March 31, 2019

 
 
June 30, 2019

 
 
September 30, 2019

 
 
December 31, 2019

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mexico
 
$
85

 
 
$
110

 
 
$
83

 
 
$
84

 
 
$
99

 
 
Chile
 
73

 
 
67

 
 
86

 
 
83

 
 
66

 
 
All other
 
56

 
 
36

 
 
49

 
 
52

 
 
73

 
 
Total sales
 
$
214

 
 
$
213

 
 
$
218

 
 
$
219

 
 
$
238

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
OTHER STATISTICAL INFORMATION
 
 
 
 
 
 
 
 
 
For the Three Months Ended
 
 
Unaudited (In millions)
 
December 31, 2018

 
 
March 31, 2019

 
 
June 30, 2019

 
 
September 30, 2019

 
 
December 31, 2019

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted premiums, fees and other revenues
 
$
956

 
 
$
942

 
 
$
1,064

 
 
$
967

 
 
$
888

 
 
Adjusted earnings available to common shareholders
 
$
137

 
 
$
134

 
 
$
159

 
 
$
155

 
 
$
161

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted premiums, fees and other revenues, on a constant currency basis
 
$
926

 
 
$
893

 
 
$
1,013

 
 
$
944

 
 
$
888

 
 
Adjusted earnings available to common shareholders, on a constant currency basis
 
$
133

 
 
$
125

 
 
$
151

 
 
$
151

 
 
$
161

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 


24


 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
EMEA
STATEMENTS OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS
 
 
 
 
For the Three Months Ended
 
For the Year Ended
 
Unaudited (In millions)
 
December 31, 2018

 
March 31, 2019

 
June 30, 2019

 
September 30, 2019

 
December 31, 2019

 
 
December 31, 2018

 
December 31, 2019

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted revenues
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Premiums
 
$
520

 
$
542

 
$
551

 
$
526

 
$
558

 
 
$
2,131

 
$
2,177

 
 
Universal life and investment-type product policy fees
 
107

 
103

 
105

 
117

 
98

 
 
431

 
423

 
 
Net investment income
 
72

 
74

 
73

 
73

 
71

 
 
293

 
291

 
 
Other revenues
 
15

 
14

 
13

 
13

 
14

 
 
66

 
54

 
 
Total adjusted revenues
 
714

 
733

 
742

 
729

 
741

 
 
2,921

 
2,945

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted expenses
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Policyholder benefits and claims and policyholder dividends
 
266

 
284

 
292

 
291

 
309

 
 
1,127

 
1,176

 
 
Interest credited to policyholder account balances
 
25

 
24

 
23

 
25

 
26

 
 
100

 
98

 
 
Capitalization of DAC
 
(120
)
 
(117
)
 
(126
)
 
(128
)
 
(134
)
 
 
(468
)
 
(505
)
 
 
Amortization of DAC and VOBA
 
110

 
92

 
107

 
128

 
101

 
 
434

 
428

 
 
Amortization of negative VOBA
 
(3
)
 
(1
)
 
(3
)
 
(2
)
 
(2
)
 
 
(15
)
 
(8
)
 
 
Interest expense on debt
 

 

 

 

 

 
 

 

 
 
Other expenses
 
355

 
338

 
350

 
341

 
370

 
 
1,378

 
1,399

 
 
Total adjusted expenses
 
633

 
620

 
643

 
655

 
670

 
 
2,556

 
2,588

 
 
Adjusted earnings before provision for income tax
 
81

 
113

 
99

 
74

 
71

 
 
365

 
357

 
 
Provision for income tax expense (benefit)
 
26

 
27

 
22

 
21

 
5

 
 
88

 
75

 
 
Adjusted earnings
 
55

 
86

 
77

 
53

 
66

 
 
277

 
282

 
 
Preferred stock dividends
 

 

 

 

 

 
 

 

 
 
Adjusted earnings available to common shareholders
 
$
55

 
$
86

 
$
77

 
$
53

 
$
66

 
 
$
277

 
$
282

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted premiums, fees and other revenues
 
$
642

 
$
659

 
$
669

 
$
656

 
$
670

 
 
$
2,628

 
$
2,654

 

25


 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
EMEA
 
 
OTHER EXPENSES BY MAJOR CATEGORY
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For the Three Months Ended
 
 
Unaudited (In millions)
 
 
December 31, 2018
 
 
March 31, 2019
 
 
June 30, 2019
 
 
September 30, 2019
 
 
December 31, 2019
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Direct and allocated expenses
 
 
$
135

 
 
$
122

 
 
$
128

 
 
$
115

 
 
$
142

 
 
Pension, postretirement and postemployment benefit costs
 
 
2

 
 
1

 
 
2

 
 
2

 
 
1

 
 
Premium taxes, other taxes, and licenses & fees
 
 
10

 
 
8

 
 
7

 
 
7

 
 
6

 
 
Commissions and other variable expenses
 
 
208

 
 
207

 
 
213

 
 
217

 
 
221

 
 
Other expenses, as reported on an adjusted basis
 
 
$
355

 
 
$
338

 
 
$
350

 
 
$
341

 
 
$
370

 
 
Other expenses, as reported on an adjusted basis, net of capitalization of DAC
 
 
$
235

 
 
$
221

 
 
$
224

 
 
$
213

 
 
$
236

 
 
Other expenses, as reported on an adjusted basis, on a constant currency basis
 
 
$
351

 
 
$
334

 
 
$
349

 
 
$
342

 
 
$
370

 
 
Other expenses, as reported on an adjusted basis, net of capitalization of DAC, on a constant currency basis
 
 
$
232

 
 
$
219

 
 
$
223

 
 
$
214

 
 
$
236

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
OTHER STATISTICAL INFORMATION
 
 
  
 
 
For the Three Months Ended
 
 
Unaudited (In millions)
 
 
December 31, 2018
 
 
March 31, 2019
 
 
June 30, 2019
 
 
September 30, 2019
 
 
December 31, 2019
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted premiums, fees and other revenues
 
 
$
642

 
 
$
659

 
 
$
669

 
 
$
656

 
 
$
670

 
 
Adjusted earnings available to common shareholders
 
 
$
55

 
 
$
86

 
 
$
77

 
 
$
53

 
 
$
66

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted premiums, fees and other revenues, on a constant currency basis
 
 
$
636

 
 
$
652

 
 
$
668

 
 
$
660

 
 
$
670

 
 
Adjusted earnings available to common shareholders, on a constant currency basis
 
 
$
54

 
 
$
84

 
 
$
77

 
 
$
53

 
 
$
66

 
 
Total sales on a constant currency basis
 
 
$
198

 
 
$
252

 
 
$
224

 
 
$
207

 
 
$
222

 

26


 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
METLIFE HOLDINGS
STATEMENTS OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS
 
 
 
For the Three Months Ended
 
For the Year Ended
 
Unaudited (In millions)
 
December 31, 2018

 
March 31, 2019

 
June 30, 2019

 
September 30, 2019

 
December 31, 2019

 
 
December 31, 2018

 
December 31, 2019

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted revenues
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Premiums
 
$
1,023

 
$
927

 
$
924

 
$
925

 
$
972

 
 
$
3,879

 
$
3,748

 
 
Universal life and investment-type product policy fees
 
317

 
274

 
286

 
284

 
280

 
 
1,218

 
1,124

 
 
Net investment income
 
1,323

 
1,287

 
1,338

 
1,316

 
1,340

 
 
5,379

 
5,281

 
 
Other revenues
 
45

 
67

 
65

 
52

 
69

 
 
250

 
253

 
 
Total adjusted revenues
 
2,708

 
2,555

 
2,613

 
2,577

 
2,661

 
 
10,726

 
10,406

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted expenses
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Policyholder benefits and claims and policyholder dividends
 
1,811

 
1,648

 
1,703

 
1,856

 
1,763

 
 
6,833

 
6,970

 
 
Interest credited to policyholder account balances
 
235

 
226

 
227

 
228

 
224

 
 
944

 
905

 
 
Capitalization of DAC
 
(8
)
 
(6
)
 
(8
)
 
(9
)
 
(5
)
 
 
(36
)
 
(28
)
 
 
Amortization of DAC and VOBA
 
118

 
63

 
80

 
94

 
62

 
 
332

 
299

 
 
Amortization of negative VOBA
 

 

 

 

 

 
 

 

 
 
Interest expense on debt
 
3

 
2

 
2

 
2

 
2

 
 
9

 
8

 
 
Other expenses
 
266

 
227

 
237

 
223

 
282

 
 
1,081

 
969

 
 
Total adjusted expenses
 
2,425

 
2,160

 
2,241

 
2,394

 
2,328

 
 
9,163

 
9,123

 
 
Adjusted earnings before provision for income tax
 
283

 
395

 
372

 
183

 
333

 
 
1,563

 
1,283

 
 
Provision for income tax expense (benefit)
 
60

 
78

 
73

 
34

 
64

 
 
308

 
249

 
 
Adjusted earnings
 
223

 
317

 
299

 
149

 
269

 
 
1,255

 
1,034

 
 
Preferred stock dividends
 

 

 

 

 

 
 

 

 
 
Adjusted earnings available to common shareholders
 
$
223

 
$
317

 
$
299

 
$
149

 
$
269

 
 
$
1,255

 
$
1,034

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted premiums, fees and other revenues
 
$
1,385

 
$
1,268

 
$
1,275

 
$
1,261

 
$
1,321

 
 
$
5,347

 
$
5,125

 

27


 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
METLIFE HOLDINGS
 
FUTURE POLICY BENEFITS AND POLICYHOLDER ACCOUNT BALANCES
 
 
 
 
 
 
 
 
 
LIFE & OTHER (1)
 
 
 
 
 
 
 
 
 
 
 
For the Three Months Ended
 
 
Unaudited (In millions)
 
December 31, 2018

 
March 31, 2019

 
June 30, 2019

 
September 30, 2019

 
 
December 31, 2019

 
 
Balance, beginning of period
 
$
80,258

 
$
80,734

 
$
80,645

 
$
80,830

 
 
$
81,118

 
 
Premiums and deposits (2), (3)
 
1,321

 
1,195

 
1,167

 
1,177

 
 
1,322

 
 
Surrenders and withdrawals
 
(627
)
 
(617
)
 
(607
)
 
(682
)
 
 
(680
)
 
 
Benefit payments
 
(721
)
 
(843
)
 
(736
)
 
(717
)
 
 
(813
)
 
 
Net flows
 
(27
)
 
(265
)
 
(176
)
 
(222
)
 
 
(171
)
 
 
Net transfers from (to) separate account
 
4

 
12

 
14

 
12

 
 
20

 
 
Interest
 
827

 
823

 
826

 
833

 
 
834

 
 
Policy charges
 
(196
)
 
(191
)
 
(189
)
 
(190
)
 
 
(188
)
 
 
Other
 
(132
)
 
(468
)
 
(290
)
 
(145
)
 
 
(452
)
 
 
Balance, end of period
 
$
80,734

 
$
80,645

 
$
80,830

 
$
81,118

 
 
$
81,161

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ANNUITIES
 
For the Three Months Ended
 
 
Unaudited (In millions)
 
December 31, 2018

 
March 31, 2019

 
June 30, 2019

 
September 30, 2019

 
 
December 31, 2019

 
 
Balance, beginning of period
 
$
19,925

 
$
19,784

 
$
19,371

 
$
19,309

 
 
$
19,402

 
 
Premiums and deposits (2), (3)
 
99

 
111

 
106

 
100

 
 
97

 
 
Surrenders and withdrawals
 
(525
)
 
(497
)
 
(414
)
 
(389
)
 
 
(512
)
 
 
Benefit payments
 
(149
)
 
(173
)
 
(160
)
 
(149
)
 
 
(161
)
 
 
Net flows
 
(575
)
 
(559
)
 
(468
)
 
(438
)
 
 
(576
)
 
 
Net transfers from (to) separate account
 
74

 
89

 
110

 
93

 
 
80

 
 
Interest
 
145

 
141

 
139

 
138

 
 
134

 
 
Policy charges
 
(4
)
 
(4
)
 
(4
)
 
(4
)
 
 
(4
)
 
 
Other
 
219

 
(80
)
 
161

 
304

 
 
(281
)
 
 
Balance, end of period
 
$
19,784

 
$
19,371

 
$
19,309

 
$
19,402

 
 
$
18,755

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SEPARATE ACCOUNT LIABILITIES
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LIFE & OTHER
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For the Three Months Ended
 
 
Unaudited (In millions)
 
December 31, 2018

 
March 31, 2019

 
June 30, 2019

 
September 30, 2019

 
 
December 31, 2019

 
 
Balance, beginning of period
 
$
5,450

 
$
4,660

 
$
5,220

 
$
5,368

 
 
$
5,324

 
 
Premiums and deposits (3)
 
66

 
67

 
63

 
62

 
 
62

 
 
Surrenders and withdrawals
 
(56
)
 
(59
)
 
(62
)
 
(61
)
 
 
(59
)
 
 
Benefit payments
 
(21
)
 
(8
)
 
(9
)
 
(9
)
 
 
(7
)
 
 
Net flows
 
(11
)
 

 
(8
)
 
(8
)
 
 
(4
)
 
 
Investment performance
 
(713
)
 
638

 
241

 
(9
)
 
 
409

 
 
Net transfers from (to) general account
 
(4
)
 
(12
)
 
(14
)
 
(12
)
 
 
(20
)
 
 
Policy charges
 
(67
)
 
(65
)
 
(66
)
 
(67
)
 
 
(66
)
 
 
Other
 
5

 
(1
)
 
(5
)
 
52

 
 
4

 
 
Balance, end of period
 
$
4,660

 
$
5,220

 
$
5,368

 
$
5,324

 
 
$
5,647

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ANNUITIES
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For the Three Months Ended
 
 
Unaudited (In millions)
 
December 31, 2018

 
March 31, 2019

 
June 30, 2019

 
September 30, 2019

 
 
December 31, 2019

 
 
Balance, beginning of period
 
$
43,128

 
$
37,549

 
$
40,136

 
$
40,255

 
 
$
39,122

 
 
Premiums and deposits (3)
 
90

 
92

 
91

 
77

 
 
79

 
 
Surrenders and withdrawals
 
(1,131
)
 
(978
)
 
(1,126
)
 
(1,070
)
 
 
(1,147
)
 
 
Benefit payments
 
(94
)
 
(100
)
 
(106
)
 
(104
)
 
 
(105
)
 
 
Net flows
 
(1,135
)
 
(986
)
 
(1,141
)
 
(1,097
)
 
 
(1,173
)
 
 
Investment performance
 
(4,157
)
 
3,854

 
1,574

 
269

 
 
2,294

 
 
Net transfers from (to) general account
 
(74
)
 
(89
)
 
(110
)
 
(93
)
 
 
(80
)
 
 
Policy charges
 
(213
)
 
(191
)
 
(205
)
 
(212
)
 
 
(201
)
 
 
Other
 

 
(1
)
 
1

 

 
 

 
 
Balance, end of period
 
$
37,549

 
$
40,136

 
$
40,255

 
$
39,122

 
 
$
39,962

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(1) Long-term care and Japan reinsurance are reported as part of "Other" within Life & Other.
 
(2) Includes premiums and deposits directed to the general account investment option of variable products.
 
(3) Includes company-sponsored internal exchanges.

28


 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
METLIFE HOLDINGS
 
 
OTHER EXPENSES BY MAJOR CATEGORY
 
 
 
 
 
 
 
 
 
  
 
For the Three Months Ended
 
 
Unaudited (In millions)
 
December 31, 2018

 
 
March 31, 2019

 
 
June 30, 2019

 
 
September 30, 2019

 
 
December 31, 2019

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Direct and allocated expenses
 
$
182

 
 
$
146

 
 
$
154

 
 
$
141

 
 
$
184

 
 
Pension, postretirement and postemployment benefit costs
 
5

 
 
8

 
 
8

 
 
7

 
 
9

 
 
Premium taxes, other taxes, and licenses & fees
 
15

 
 
18

 
 
18

 
 
17

 
 
14

 
 
Commissions and other variable expenses
 
64

 
 
55

 
 
57

 
 
58

 
 
75

 
 
Other expenses, as reported on an adjusted basis
 
$
266

 
 
$
227

 
 
$
237

 
 
$
223

 
 
$
282

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
OTHER STATISTICAL INFORMATION
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For the Three Months Ended
 
 
Unaudited (In millions, except ratios)
 
December 31, 2018

 
 
March 31, 2019

 
 
June 30, 2019

 
 
September 30, 2019

 
 
December 31, 2019

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Life (1)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted premiums, fees and other revenues
 
$
964

 
 
$
849

 
 
$
851

 
 
$
845

 
 
$
906

 
 
Interest adjusted benefit ratio
 
58.0
%
 
 
50.0
%
 
 
53.9
%
 
 
67.5
%
 
 
55.5
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Lapse Ratio (2)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Traditional life
 
5.2
%
 
 
4.8
%
 
 
4.8
%
 
 
4.8
%
 
 
4.8
%
 
 
Variable & universal life
 
4.4
%
 
 
4.3
%
 
 
4.2
%
 
 
4.2
%
 
 
4.1
%
 
 
Fixed annuity
 
8.6
%
 
 
10.2
%
 
 
10.7
%
 
 
10.7
%
 
 
11.3
%
 
 
Variable annuity
 
10.2
%
 
 
10.1
%
 
 
10.2
%
 
 
10.2
%
 
 
10.2
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(1) Represents traditional life and variable & universal life, components of Life & Other.
 
 
(2) Lapse ratios are calculated based on the average of the most recent 12 months of experience.
 


29


 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CORPORATE & OTHER
STATEMENTS OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS
 
 
 
For the Three Months Ended
 
For the Year Ended
 
Unaudited (In millions)
 
December 31, 2018

 
March 31, 2019

 
June 30, 2019

 
September 30, 2019

 
December 31, 2019

 
 
December 31, 2018

 
December 31, 2019

 
 
Adjusted revenues
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Premiums
 
$
132

 
$
24

 
$
16

 
$
35

 
$
8

 
 
$
118

 
$
83

 
 
Universal life and investment-type product policy fees
 

 
1

 

 
1

 

 
 

 
2

 
 
Net investment income
 
21

 
25

 
44

 
114

 
92

 
 
178

 
275

 
 
Other revenues
 
87

 
94

 
82

 
36

 
79

 
 
333

 
291

 
 
Total adjusted revenues
 
240

 
144

 
142

 
186

 
179

 
 
629

 
651

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted expenses
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Policyholder benefits and claims and policyholder dividends
 
118

 
20

 
18

 
32

 
3

 
 
80

 
73

 
 
Interest credited to policyholder account balances
 

 

 

 

 

 
 

 

 
 
Capitalization of DAC
 
(1
)
 
(2
)
 
(4
)
 
(3
)
 
(3
)
 
 
(8
)
 
(12
)
 
 
Amortization of DAC and VOBA
 
1

 
1

 
2

 
2

 
1

 
 
6

 
6

 
 
Amortization of negative VOBA
 

 

 

 

 

 
 

 

 
 
Interest expense on debt
 
234

 
229

 
268

 
218

 
219

 
 
1,032

 
934

 
 
Other expenses
 
102

 
222

 
289

 
320

 
243

 
 
907

 
1,074

 
 
Total adjusted expenses
 
454

 
470

 
573

 
569

 
463

 
 
2,017

 
2,075

 
 
Adjusted earnings before provision for income tax
 
(214
)
 
(326
)
 
(431
)
 
(383
)
 
(284
)
 
 
(1,388
)
 
(1,424
)
 
 
Provision for income tax expense (benefit)
 
(226
)
 
(165
)
 
(181
)
 
(192
)
 
(663
)
 
 
(825
)
 
(1,201
)
 
 
Adjusted earnings
 
12

 
(161
)
 
(250
)
 
(191
)
 
379

 
 
(563
)
 
(223
)
 
 
Preferred stock dividends
 
57

 
32

 
57

 
32

 
57

 
 
141

 
178

 
 
Adjusted earnings available to common shareholders
 
$
(45
)
 
$
(193
)
 
$
(307
)
 
$
(223
)
 
$
322

 
 
$
(704
)
 
$
(401
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted premiums, fees and other revenues
 
$
219

 
$
119

 
$
98

 
$
72

 
$
87

 
 
$
451

 
$
376

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS BY SOURCE
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
For the Three Months Ended
 
For the Year Ended
 
Unaudited (In millions)
 
December 31, 2018

 
March 31, 2019

 
June 30, 2019

 
September 30, 2019

 
December 31, 2019

 
 
December 31, 2018

 
December 31, 2019

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Business activities
 
$
10

 
$
13

 
$
12

 
$
25

 
$
20

 
 
$
41

 
$
70

 
 
Net investment income
 
49

 
29

 
46

 
114

 
101

 
 
263

 
290

 
 
Interest expense on debt
 
(245
)
 
(239
)
 
(280
)
 
(229
)
 
(230
)
 
 
(1,076
)
 
(978
)
 
 
Corporate initiatives and projects
 
(137
)
 
(100
)
 
(117
)
 
(151
)
 
(195
)
 
 
(405
)
 
(563
)
 
 
Other
 
(90
)
 
(29
)
 
(92
)
 
(142
)
 
(67
)
 
 
(368
)
 
(330
)
 
 
Provision for income tax (expense) benefit and other tax-related items
 
425

 
165

 
181

 
192

 
750

 
 
982

 
1,288

 
 
Preferred stock dividends
 
(57
)
 
(32
)
 
(57
)
 
(32
)
 
(57
)
 
 
(141
)
 
(178
)
 
 
Adjusted earnings available to common shareholders
 
$
(45
)
 
$
(193
)
 
$
(307
)
 
$
(223
)
 
$
322

 
 
$
(704
)
 
$
(401
)
 

30


 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INVESTMENTS
INVESTMENT PORTFOLIO RESULTS BY ASSET CATEGORY AND ANNUALIZED YIELDS
 
 
This yield table presentation is consistent with how we measure our investment performance for management purposes, and we believe it enhances understanding of our investment portfolio results.
 
 
 
At or For the Three Months Ended (1)
 
 
 
At or For the Year Ended (1)
 
 
Unaudited (In millions, except yields)
 
December 31, 2018

 
March 31, 2019

 
June 30, 2019

 
September 30, 2019

 
 
December 31, 2019

 
 
 
December 31, 2018

 
December 31, 2019

 
 
Fixed Maturity Securities
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Yield
 
4.23
 %
 
4.23
 %
 
4.30
 %
 
4.15
 %
 
 
4.19
 %
 
 
 
4.26
 %
 
4.22
 %
 
 
Investment income (2), (3)
 
$
2,914

 
$
2,902

 
$
2,975

 
$
2,901

 
 
$
2,965

 
 
 
$
11,678

 
$
11,743

 
 
Investment gains (losses)
 
40

 
(24
)
 
138

 
82

 
 
71

 
 
 
5

 
267

 
 
Ending carrying value (4)
 
299,136

 
309,368

 
319,696

 
327,203

 
 
329,067

 
 
 
299,136

 
329,067

 
 
Mortgage Loans
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Yield
 
4.72
 %
 
4.73
 %
 
4.82
 %
 
4.74
 %
 
 
5.00
 %
 
 
 
4.66
 %
 
4.82
 %
 
 
Investment income (3)
 
874

 
912

 
943

 
929

 
 
998

 
 
 
3,340

 
3,782

 
 
Investment gains (losses)
 
(24
)
 
(15
)
 
14

 
(16
)
 
 
6

 
 
 
(56
)
 
(11
)
 
 
Ending carrying value
 
75,752

 
78,601

 
77,997

 
78,959

 
 
80,529

 
 
 
75,752

 
80,529

 
 
Real Estate and Real Estate Joint Ventures
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Yield
 
2.83
 %
 
2.04
 %
 
3.62
 %
 
3.53
 %
 
 
3.58
 %
 
 
 
3.59
 %
 
3.20
 %
 
 
Investment income
 
70

 
50

 
92

 
91

 
 
94

 
 
 
352

 
327

 
 
Investment gains (losses)
 
172

 
5

 
1

 
96

 
 
297

 
 
 
326

 
399

 
 
Ending carrying value
 
9,698

 
10,022

 
10,326

 
10,246

 
 
10,741

 
 
 
9,698

 
10,741

 
 
Policy Loans
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Yield
 
5.16
 %
 
5.28
 %
 
5.34
 %
 
5.33
 %
 
 
5.21
 %
 
 
 
5.21
 %
 
5.29
 %
 
 
Investment income
 
125

 
128

 
129

 
129

 
 
126

 
 
 
506

 
512

 
 
Ending carrying value
 
9,699

 
9,670

 
9,705

 
9,671

 
 
9,680

 
 
 
9,699

 
9,680

 
 
Equity Securities
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Yield
 
6.09
 %
 
5.43
 %
 
5.15
 %
 
4.62
 %
 
 
5.85
 %
 
 
 
4.79
 %
 
5.25
 %
 
 
Investment income
 
19

 
16

 
16

 
13

 
 
16

 
 
 
64

 
61

 
 
Investment gains (losses)
 
(96
)
 
107

 
(2
)
 
17

 
 
12

 
 
 
(75
)
 
134

 
 
Ending carrying value
 
1,440

 
1,432

 
1,476

 
1,341

 
 
1,342

 
 
 
1,440

 
1,342

 
 
Other Limited Partnership Interests
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Yield
 
12.47
 %
 
7.59
 %
 
14.28
 %
 
15.37
 %
 
 
9.87
 %
 
 
 
12.97
 %
 
11.81
 %
 
 
Investment income
 
203

 
127

 
247

 
279

 
 
187

 
 
 
792

 
840

 
 
Investment gains (losses)
 

 
(1
)
 
1

 
3

 
 
3

 
 
 
9

 
6

 
 
Ending carrying value
 
6,613

 
6,787

 
7,054

 
7,441

 
 
7,716

 
 
 
6,613

 
7,716

 
 
Cash and Short-term Investments
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Yield
 
2.67
 %
 
3.08
 %
 
2.39
 %
 
2.31
 %
 
 
2.09
 %
 
 
 
2.41
 %
 
2.47
 %
 
 
Investment income
 
66

 
79

 
65

 
62

 
 
50

 
 
 
244

 
256

 
 
Investment gains (losses)
 
2

 

 
(5
)
 
(1
)
 
 
9

 
 
 
(6
)
 
3

 
 
Ending carrying value
 
19,758

 
19,030

 
21,246

 
22,988

 
 
20,448

 
 
 
19,758

 
20,448

 
 
Other Invested Assets
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investment income
 
217

 
203

 
225

 
226

 
 
247

 
 
 
887

 
901

 
 
Investment gains (losses)
 
5

 
(67
)
 
(38
)
 
(30
)
 
 
(10
)
 
 
 
(162
)
 
(145
)
 
 
Ending carrying value
 
18,190

 
18,175

 
20,036

 
21,979

 
 
19,015

 
 
 
18,190

 
19,015

 
 
Total Investments
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investment income yield
 
4.54
 %
 
4.44
 %
 
4.66
 %
 
4.57
 %
 
 
4.57
 %
 
 
 
4.56
 %
 
4.56
 %
 
 
Investment fees and expenses yield
 
(0.12
)%
 
(0.14
)%
 
(0.14
)%
 
(0.13
)%
 
 
(0.13
)%
 
 
 
(0.12
)%
 
(0.14
)%
 
 
Net Investment Income Yield
 
4.42
 %
 
4.30
 %
 
4.52
 %
 
4.44
 %
 
 
4.44
 %
 
 
 
4.44
 %
 
4.42
 %
 
 
Investment income
 
$
4,488

 
$
4,417

 
$
4,692

 
$
4,630

 
 
$
4,683

 
 
 
$
17,863

 
$
18,422

 
 
Investment fees and expenses
 
(113
)
 
(136
)
 
(138
)
 
(134
)
 
 
(137
)
 
 
 
(479
)
 
(545
)
 
 
Net investment income including Divested businesses
 
4,375

 
4,281

 
4,554

 
4,496

 
 
4,546

 
 
 
17,384

 
17,877

 
 
Less: Net investment income from Divested businesses
 

 

 

 
23

 
 
24

 
 
 
1

 
47

 
 
Net Investment Income, as reported on an adjusted basis (5)
 
$
4,375

 
$
4,281

 
$
4,554

 
$
4,473

 
 
$
4,522

 
 
 
$
17,383

 
$
17,830

 
 
Ending Carrying Value
 
$
440,286

 
$
453,085

 
$
467,536

 
$
479,828

 
 
$
478,538

 
 
 
$
440,286

 
$
478,538

 
 
Gross investment gains
 
$
569

 
$
375

 
$
328

 
$
332

 
 
$
672

 
 
 
$
1,499

 
$
1,707

 
 
Gross investment losses
 
(440
)
 
(271
)
 
(189
)
 
(159
)
 
 
(144
)
 
 
 
(1,279
)
 
(763
)
 
 
Writedowns
 
(30
)
 
(99
)
 
(30
)
 
(22
)
 
 
(140
)
 
 
 
(179
)
 
(291
)
 
 
Investment Portfolio Gains (Losses) (6)
 
99

 
5

 
109

 
151

 
 
388

 
 
 
41

 
653

 
 
Investment portfolio gains (losses) income tax (expense) benefit
 
(10
)
 
(17
)
 
(26
)
 
(64
)
 
 
(96
)
 
 
 
(75
)
 
(203
)
 
 
Investment Portfolio Gains (Losses), Net of Income Tax
 
$
89

 
$
(12
)
 
$
83

 
$
87

 
 
$
292

 
 
 
$
(34
)
 
$
450

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Derivative gains (losses) (6)
 
$
824

 
$
15

 
$
614

 
$
1,141

 
 
$
(1,583
)
 
 
 
$
399

 
$
187

 
 
Derivative gains (losses) income tax (expense) benefit
 
(201
)
 
(18
)
 
(150
)
 
(259
)
 
 
364

 
 
 
(103
)
 
(63
)
 
 
Derivative Gains (Losses), Net of Income Tax
 
$
623

 
$
(3
)
 
$
464

 
$
882

 
 
$
(1,219
)
 
 
 
$
296

 
$
124

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
See footnotes on Page 34.
 
 
 
 
 
 


31


 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INVESTMENTS
 
 
 
SUMMARY OF FIXED MATURITY SECURITIES AVAILABLE-FOR-SALE
BY SECTOR AND QUALITY DISTRIBUTION
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
December 31, 2018
 
March 31, 2019
 
June 30, 2019
 
September 30, 2019
 
 
December 31, 2019
 
 
Unaudited (In millions, except ratios)
 
Amount
 
% of Total
 
Amount
 
% of Total
 
Amount
 
% of Total
 
Amount
 
% of Total
 
 
Amount
 
% of Total
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
U.S. corporate securities
 
$
78,948

 
26.4
%
 
$
80,146

 
26.0
%
 
$
83,712

 
26.3
%
 
$
87,114

 
26.7
%
 
 
$
87,753

 
26.8
%
 
 
Foreign government securities
 
62,288

 
20.9
%
 
64,955

 
21.1
%
 
67,554

 
21.2
%
 
67,547

 
20.7
%
 
 
67,229

 
20.5
%
 
 
Foreign corporate securities
 
56,703

 
19.0
%
 
59,945

 
19.4
%
 
62,398

 
19.6
%
 
63,100

 
19.3
%
 
 
64,165

 
19.6
%
 
 
U.S. government and agency securities
 
39,322

 
13.2
%
 
41,008

 
13.3
%
 
40,003

 
12.6
%
 
40,802

 
12.5
%
 
 
42,084

 
12.8
%
 
 
Residential mortgage-backed securities
 
27,961

 
9.4
%
 
28,360

 
9.2
%
 
29,049

 
9.1
%
 
29,591

 
9.1
%
 
 
28,547

 
8.7
%
 
 
Asset-backed securities
 
12,472

 
4.2
%
 
12,631

 
4.1
%
 
13,712

 
4.3
%
 
14,345

 
4.4
%
 
 
14,542

 
4.4
%
 
 
Municipals
 
11,533

 
3.9
%
 
11,898

 
3.8
%
 
12,255

 
3.8
%
 
12,942

 
4.0
%
 
 
13,053

 
4.0
%
 
 
Commercial mortgage-backed securities
 
9,038

 
3.0
%
 
9,467

 
3.1
%
 
10,006

 
3.1
%
 
10,608

 
3.3
%
 
 
10,447

 
3.2
%
 
 
Fixed Maturity Securities Available-For-Sale
 
$
298,265

 
100.0
%
 
$
308,410

 
100.0
%
 
$
318,689

 
100.0
%
 
$
326,049

 
100.0
%
 
 
$
327,820

 
100.0
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NAIC
 
NRSRO
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DESIGNATION
 
RATING
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
 
Aaa / Aa / A
 
$
208,806

 
70.0
%
 
$
216,343

 
70.1
%
 
$
223,594

 
70.2
%
 
$
229,104

 
70.3
%
 
 
$
230,708

 
70.4
%
 
 
2
 
Baa
 
73,141

 
24.5
%
 
75,769

 
24.6
%
 
78,943

 
24.8
%
 
81,478

 
25.0
%
 
 
81,425

 
24.8
%
 
 
3
 
Ba
 
11,158

 
3.7
%
 
11,350

 
3.7
%
 
11,490

 
3.6
%
 
11,400

 
3.5
%
 
 
11,652

 
3.6
%
 
 
4
 
B
 
4,498

 
1.6
%
 
4,324

 
1.4
%
 
4,176

 
1.3
%
 
3,423

 
1.0
%
 
 
3,337

 
1.0
%
 
 
5
 
Caa and lower
 
647

 
0.2
%
 
591

 
0.2
%
 
451

 
0.1
%
 
609

 
0.2
%
 
 
693

 
0.2
%
 
 
6
 
In or near default
 
15

 
%
 
33

 
%
 
35

 
%
 
35

 
%
 
 
5

 
%
 
 
Fixed Maturity Securities Available-For-Sale (7)
 
$
298,265

 
100.0
%
 
$
308,410

 
100.0
%
 
$
318,689

 
100.0
%
 
$
326,049

 
100.0
%
 
 
$
327,820

 
100.0
%
 
 
 
 
 
 
 
GROSS UNREALIZED GAINS AND LOSSES AGING SCHEDULE
 
 
 
 
FIXED MATURITY SECURITIES AVAILABLE-FOR-SALE (8)
 
 
 
 
 
 
 
December 31, 2018
 
March 31, 2019
 
June 30, 2019
 
September 30, 2019
 
 
December 31, 2019
 
 
Unaudited (In millions, except ratios)
 
Amount
 
% of Total
 
Amount
 
% of Total
 
Amount
 
% of Total
 
Amount
 
% of Total
 
 
Amount
 
% of Total
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Less than 20%
 
$
5,340

 
89.7
%
 
$
2,563

 
91.2
%
 
$
1,542

 
80.6
%
 
$
1,499

 
73.3
%
 
 
$
1,370

 
83.2
%
 
 
20% or more for less than six months
 
460

 
7.7
%
 
135

 
4.8
%
 
215

 
11.2
%
 
370

 
18.1
%
 
 
116

 
7.0
%
 
 
20% or more for six months or greater
 
155

 
2.6
%
 
113

 
4.0
%
 
156

 
8.2
%
 
176

 
8.6
%
 
 
161

 
9.8
%
 
 
Gross Unrealized Losses
 
$
5,955

 
100.0
%
 
$
2,811

 
100.0
%
 
$
1,913

 
100.0
%
 
$
2,045

 
100.0
%
 
 
$
1,647

 
100.0
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gross Unrealized Gains
 
$
17,404

 
 
 
$
22,662

 
 
 
$
29,373

 
 
 
$
34,964

 
 
 
 
$
31,812

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
See footnotes on Page 34.


32


 
INVESTMENTS
 
 
 
 
SUMMARY OF MORTGAGE LOANS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Unaudited (In millions)
 
December 31, 2018
 
March 31, 2019
 
June 30, 2019
 
September 30, 2019
 
 
December 31, 2019
 
 
 
 
  
 
  
 
  
 
  
 
 
  
 
 
Commercial mortgage loans
 
$
48,463

 
 
 
$
49,960

 
 
 
$
49,570

 
 
 
$
49,898

 
 
 
 
$
49,624

 
 
 
 
Agricultural mortgage loans
 
14,905

 
 
 
15,130

 
 
 
15,334

 
 
 
15,752

 
 
 
 
16,695

 
 
 
 
Residential mortgage loans
 
12,726

 
 
 
13,861

 
 
 
13,450

 
 
 
13,659

 
 
 
 
14,504

 
 
 
 
Mortgage loans held-for-sale
 

 
 
 

 
 
 

 
 
 

 
 
 
 
59

 
 
 
 
Mortgage Loans
 
76,094

 
 
 
78,951

 
 
 
78,354

 
 
 
79,309

 
 
 
 
80,882

 
 
 
 
Valuation allowances
 
(342
)
 
 
 
(350
)
 
 
 
(357
)
 
 
 
(350
)
 
 
 
 
(353
)
 
 
 
 
Mortgage Loans, net
 
$
75,752

 
 
 
$
78,601

 
 
 
$
77,997

 
 
 
$
78,959

 
 
 
 
$
80,529

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SUMMARY OF COMMERCIAL MORTGAGE LOANS
BY REGION AND PROPERTY TYPE
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
December 31, 2018
 
March 31, 2019
 
June 30, 2019
 
September 30, 2019
 
 
December 31, 2019
 
 
Unaudited (In millions, except ratios)
 
Amount
 
% of Total
 
Amount
 
% of Total
 
Amount
 
% of Total
 
Amount
 
% of Total
 
 
Amount
 
% of Total
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Pacific
 
$
10,884

 
22.5
%
 
$
10,683

 
21.4
%
 
$
10,511

 
21.2
%
 
$
10,079

 
20.2
%
 
 
$
10,169

 
20.5
%
 
 
Non-U.S.
 
9,281

 
19.1
%
 
9,727

 
19.5
%
 
9,463

 
19.1
%
 
9,480

 
19.0
%
 
 
10,093

 
20.3
%
 
 
Middle Atlantic
 
7,911

 
16.3
%
 
7,873

 
15.7
%
 
7,952

 
16.0
%
 
8,210

 
16.4
%
 
 
8,302

 
16.7
%
 
 
South Atlantic
 
6,347

 
13.1
%
 
6,427

 
12.9
%
 
6,459

 
13.0
%
 
6,896

 
13.8
%
 
 
6,487

 
13.1
%
 
 
West South Central
 
3,951

 
8.1
%
 
4,299

 
8.6
%
 
4,386

 
8.9
%
 
4,454

 
8.9
%
 
 
4,255

 
8.6
%
 
 
East North Central
 
2,840

 
5.9
%
 
3,269

 
6.5
%
 
3,245

 
6.6
%
 
3,225

 
6.5
%
 
 
3,066

 
6.2
%
 
 
Mountain
 
1,387

 
2.9
%
 
1,501

 
3.0
%
 
1,729

 
3.5
%
 
1,774

 
3.6
%
 
 
1,602

 
3.2
%
 
 
New England
 
1,481

 
3.1
%
 
1,479

 
3.0
%
 
1,628

 
3.3
%
 
1,705

 
3.4
%
 
 
1,433

 
2.9
%
 
 
West North Central
 
594

 
1.2
%
 
594

 
1.2
%
 
593

 
1.2
%
 
592

 
1.2
%
 
 
607

 
1.2
%
 
 
East South Central
 
564

 
1.2
%
 
563

 
1.1
%
 
563

 
1.1
%
 
530

 
1.1
%
 
 
502

 
1.0
%
 
 
Multi-Region and Other
 
3,223

 
6.6
%
 
3,545

 
7.1
%
 
3,041

 
6.1
%
 
2,953

 
5.9
%
 
 
3,108

 
6.3
%
 
 
Total
 
$
48,463

 
100.0
%
 
$
49,960

 
100.0
%
 
$
49,570

 
100.0
%
 
$
49,898

 
100.0
%
 
 
$
49,624

 
100.0
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Office
 
$
23,995

 
49.5
%
 
$
24,514

 
49.1
%
 
$
23,755

 
47.9
%
 
$
23,455

 
47.0
%
 
 
$
22,925

 
46.2
%
 
 
Retail
 
9,089

 
18.7
%
 
9,387

 
18.8
%
 
9,577

 
19.3
%
 
9,707

 
19.5
%
 
 
9,052

 
18.2
%
 
 
Apartment
 
7,018

 
14.5
%
 
6,943

 
13.9
%
 
6,960

 
14.1
%
 
6,906

 
13.8
%
 
 
8,212

 
16.6
%
 
 
Industrial
 
3,719

 
7.7
%
 
3,761

 
7.5
%
 
3,748

 
7.6
%
 
4,226

 
8.5
%
 
 
3,985

 
8.0
%
 
 
Hotel
 
3,479

 
7.2
%
 
3,716

 
7.4
%
 
3,688

 
7.4
%
 
3,617

 
7.2
%
 
 
3,471

 
7.0
%
 
 
Other
 
1,163

 
2.4
%
 
1,639

 
3.3
%
 
1,842

 
3.7
%
 
1,987

 
4.0
%
 
 
1,979

 
4.0
%
 
 
Total
 
$
48,463

 
100.0
%
 
$
49,960

 
100.0
%
 
$
49,570

 
100.0
%
 
$
49,898

 
100.0
%
 
 
$
49,624

 
100.0
%
 


33


 
 
 
 
 
 
 
 
 
 
 
INVESTMENTS
FOOTNOTES
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(1) We calculate yields using average quarterly asset carrying values. Yields exclude the impact of recognized gains and losses, includes the impact of changes in foreign currency exchange rates and reflects the adjustments described on Page A-7 and presented on Page 5. Asset carrying values exclude unrealized gains (losses), collateral received in connection with our securities lending program, annuities funding structured settlement claims, freestanding derivative assets, collateral received from derivative counterparties, the effects of consolidating under GAAP certain VIEs that are treated as CSEs and contractholder-directed equity securities. A yield is not presented for other invested assets, as it is not considered a meaningful measure of performance for this asset class.
 
(2) Fixed maturity securities includes investment income related to fair value option securities of $26 million, $55 million, $38 million, $59 million and $32 million for the three months ended December 31, 2018, March 31, 2019, June 30, 2019, September 30, 2019 and December 31, 2019, respectively, and $51 million and $184 million for the year ended December 31, 2018 and December 31, 2019, respectively.
 
(3) Investment income from fixed maturity securities and mortgage loans includes prepayment fees.
 
(4) The following table presents the components of total fixed maturity securities and a reconciliation to ending carrying value presented for fixed maturity securities.
 
 
December 31, 2018

March 31, 2019

June 30, 2019

September 30, 2019

December 31, 2019

 
 
 
 
Fixed maturity securities available-for-sale
$
298,265

$
308,410

$
318,689

$
326,049

$
327,820

 
 
 
 
Contractholder-directed equity securities and fair value option securities
12,616

13,245

13,000

12,671

13,102

 
 
 
 
Total fixed maturity securities
310,881

321,655

331,689

338,720

340,922

 
 
 
 
Less: Contractholder-directed equity securities
11,741

12,284

11,990

11,514

11,852

 
 
 
 
Less: Effects of consolidating under GAAP certain VIEs that are treated as CSEs
4

3

3

3

3

 
 
 
 
Fixed maturity securities
$
299,136

$
309,368

$
319,696

$
327,203

$
329,067

 
 
 
 
 
 
 
 
 
 
 
 
 
 
(5) Net investment income, as reported on an adjusted basis, reflects the adjustments as presented on Page 5.
 
(6) Investment portfolio gains (losses) and Derivative gains (losses) reflect the non-GAAP adjustments as presented below:
 
 
For the Three Months Ended
 
For the Year Ended
 
 
December 31, 2018

March 31, 2019

June 30, 2019

September 30, 2019

December 31, 2019

 
December 31, 2018

December 31, 2019

 
Net investment gains (losses)
$
145

$
15

$
61

$
161

$
207

 
$
(298
)
$
444

 
Less: Operating joint venture adjustments





 
(1
)

 
Less: Change in estimated fair value of other limited partnership interests and real estate joint ventures
6

(15
)
3

(1
)
(1
)
 
12

(14
)
 
Less: Non-investment portfolio gains (losses)
40

25

(51
)
11

(180
)
 
(350
)
(195
)
 
Investment portfolio gains (losses)
$
99

$
5

$
109

$
151

$
388

 
$
41

$
653

 
 
 
 
 
 
 
 
 
 
 
 
For the Three Months Ended
 
For the Year Ended
 
 
December 31, 2018

March 31, 2019

June 30, 2019

September 30, 2019

December 31, 2019

 
December 31, 2018

December 31, 2019

 
Net derivative gains (losses)
$
939

$
115

$
724

$
1,254

$
(1,465
)
 
$
851

$
628

 
Less: Investment hedge adjustments
121

105

118

121

125

 
475

469

 
Less: Settlement of foreign currency earnings hedges
(5
)
(2
)
(2
)
(3
)
(2
)
 
(19
)
(9
)
 
Less: PAB hedge adjustments
(1
)
(3
)
(6
)
(5
)
(5
)
 
(4
)
(19
)
 
Derivative gains (losses)
$
824

$
15

$
614

$
1,141

$
(1,583
)
 
$
399

$
187

 
 
 
 
 
 
 
 
 
 
 
(7) Amounts presented are based on ratings of NRSRO and the applicable NAIC designation from the NAIC published comparison of NRSRO ratings to NAIC designations, except for certain mortgage-backed securities (non-agency residential mortgage-backed securities and commercial mortgage-backed securities). NRSRO ratings are based on availability of applicable ratings. If no NRSRO rating is available, then an internally developed rating is used. Amounts presented for certain mortgage-backed securities held by MetLife, Inc.'s insurance subsidiaries that maintain the NAIC statutory basis of accounting reflect designations based on revised NAIC methodologies. The NAIC's present methodology is to evaluate certain mortgage-backed securities held by insurers using the revised NAIC methodologies on an annual basis. An internally developed designation is used until a final designation becomes available from the NAIC annual review. These revised NAIC designations may not correspond to NRSRO ratings.
 
(8) MetLife's review of its fixed maturity securities for impairments includes an analysis of the total gross unrealized losses by three categories of securities: (i) securities where the estimated fair value had declined and remained below amortized cost by less than 20%; (ii) securities where the estimated fair value had declined and remained below amortized cost by 20% or more for less than six months; and (iii) securities where the estimated fair value had declined and remained below amortized cost by 20% or more for six months or greater.

34


imagj97.jpg
Appendix







 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
APPENDIX
METLIFE
RECONCILIATION DETAIL
 
 
 
 
 
 
 
 
 
 
 
For the Three Months Ended
 
 
For the Year Ended
 
Unaudited (In millions)
 
December 31, 2018

 
March 31, 2019

 
June 30, 2019

 
September 30, 2019

 
 
December 31, 2019

 
 
December 31, 2018

 
December 31, 2019

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Reconciliation to Adjusted Earnings Available to Common Shareholders
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss) available to MetLife, Inc.'s common shareholders
 
$
2,010

 
$
1,349

 
$
1,684

 
$
2,152

 
 
$
536

 
 
$
4,982

 
$
5,721

 
 
Add: Preferred stock dividends
 
57

 
32

 
57

 
32

 
 
57

 
 
141

 
178

 
 
Add: Net Income (loss) attributable to noncontrolling interests
 
(5
)
 
4

 
5

 
6

 
 
(5
)
 
 
5

 
10

 
 
Less: Income (loss) from discontinued operations, net of income tax
 

 

 

 

 
 

 
 

 

 
 
Income (loss) from continuing operations, net of income tax
 
2,062

 
1,385

 
1,746

 
2,190

 
 
588

 
 
$
5,128

 
$
5,909

 
 
Less: adjustments from income (loss) from continuing operations, net of income tax, to adjusted earnings:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment gains (losses)
 
145

 
15

 
61

 
161

 
 
207

 
 
(298
)
 
444

 
 
Net derivative gains (losses)
 
939

 
115

 
724

 
1,254

 
 
(1,465
)
 
 
851

 
628

 
 
Premiums - Divested businesses
 

 

 

 
35

 
 
36

 
 

 
71

 
 
Universal life and investment-type product policy fees
 

 

 

 

 
 

 
 

 
 
 
 
Unearned revenue adjustments
 
(8
)
 

 
20

 
59

 
 
18

 
 
(7
)
 
97

 
 
GMIB fees
 
27

 
27

 
28

 
27

 
 
26

 
 
120

 
108

 
 
Divested businesses
 

 

 

 
2

 
 
1

 
 
7

 
3

 
 
Net investment income
 

 

 

 

 
 

 
 

 

 
 
Investment hedge adjustments
 
(121
)
 
(105
)
 
(118
)
 
(121
)
 
 
(125
)
 
 
(475
)
 
(469
)
 
 
Operating joint venture adjustments
 

 

 

 

 
 

 
 
1

 

 
 
Unit-linked contract income
 
(765
)
 
736

 
261

 
250

 
 
228

 
 
(683
)
 
1,475

 
 
Securitization entities income
 

 

 

 

 
 

 
 

 

 
 
Certain partnership distributions
 
(27
)
 
(4
)
 
(4
)
 
(2
)
 
 
(5
)
 
 
(61
)
 
(15
)
 
 
Divested businesses
 

 

 

 
23

 
 
24

 
 
1

 
47

 
 
Other revenues
 

 

 

 

 
 

 
 

 

 
 
Settlement of foreign currency earnings hedges
 
5

 
2

 
2

 
3

 
 
2

 
 
19

 
9

 
 
TSA fees
 
70

 
68

 
69

 
69

 
 
40

 
 
305

 
246

 
 
Divested businesses
 

 

 

 

 
 
2

 
 

 
2

 
 
Policyholder benefits and claims and policyholder dividends
 

 

 

 

 
 

 
 

 

 
 
PBC hedge adjustments
 

 

 

 
(9
)
 
 
(10
)
 
 

 
(19
)
 
 
PDO adjustments
 

 

 

 

 
 

 
 

 

 
 
Inflation and pass-through adjustments
 
(1
)
 
(79
)
 
(84
)
 
(87
)
 
 
6

 
 
(29
)
 
(244
)
 
 
GMIB costs
 
78

 
(56
)
 
(39
)
 
47

 
 
(106
)
 
 
(146
)
 
(154
)
 
 
Market value adjustments
 
1

 
4

 
11

 
(3
)
 
 
(8
)
 
 
1

 
4

 
 
Divested businesses
 

 

 

 
(34
)
 
 
(33
)
 
 

 
(67
)
 
 
Interest credited to policyholder account balances
 

 

 

 

 
 

 
 

 

 
 
PAB hedge adjustments
 
1

 
3

 
6

 
5

 
 
5

 
 
4

 
19

 
 
Unit-linked contract costs
 
730

 
(716
)
 
(257
)
 
(223
)
 
 
(240
)
 
 
676

 
(1,436
)
 
 
Divested businesses
 

 

 

 
(8
)
 
 
(10
)
 
 

 
(18
)
 
 
Capitalization of DAC - Divested businesses
 

 

 

 
11

 
 
9

 
 
1

 
20

 
 
Amortization of DAC and VOBA
 

 

 

 

 
 

 
 

 

 
 
Related to NIGL and NDGL
 
(44
)
 
24

 
5

 
(39
)
 
 
(106
)
 
 
(109
)
 
(116
)
 
 
Related to GMIB fees and GMIB costs
 
(68
)
 
7

 
3

 

 
 
1

 
 
(106
)
 
11

 
 
Related to market value adjustments
 

 

 

 

 
 

 
 

 

 
 
Divested businesses
 

 

 

 
(2
)
 
 
(2
)
 
 

 
(4
)
 
 
Amortization of negative VOBA
 

 

 

 

 
 

 
 

 

 
 
Related to market value adjustments
 

 

 

 

 
 

 
 
1

 

 
 
Divested businesses
 

 

 

 

 
 

 
 

 

 
 
Interest expense on debt
 

 

 

 

 
 

 
 

 

 
 
Securitization entities debt expense
 

 

 

 

 
 

 
 

 

 
 
Divested businesses
 
(18
)
 

 

 

 
 

 
 
(63
)
 

 
 
Other expenses
 

 

 

 

 
 

 
 

 

 
 
Noncontrolling interest
 
(5
)
 
6

 
6

 
8

 
 
(5
)
 
 
10

 
15

 
 
Regulatory implementation costs
 
(5
)
 
(3
)
 
(7
)
 
(5
)
 
 
(3
)
 
 
(11
)
 
(18
)
 
 
Acquisition, integration and other costs
 
14

 
(23
)
 
(6
)
 
(8
)
 
 
(7
)
 
 
(24
)
 
(44
)
 
 
TSA fees
 
(70
)
 
(68
)
 
(69
)
 
(69
)
 
 
(40
)
 
 
(305
)
 
(246
)
 
 
Divested businesses
 
4

 

 
(6
)
 
(36
)
 
 
(116
)
 
 
(68
)
 
(158
)
 
 
Goodwill impairment
 

 

 

 

 
 

 
 

 

 
 
Provision for income tax (expense) benefit
 
(213
)
 
(24
)
 
(236
)
 
(340
)
 
 
373

 
 
(86
)
 
(227
)
 
 
Adjusted earnings
 
1,393

 
1,456

 
1,376

 
1,222

 
 
1,891

 
 
5,602

 
5,945

 
 
Less: Preferred stock dividends
 
57

 
32

 
57

 
32

 
 
57

 
 
141

 
178

 
 
Adjusted earnings available to common shareholders
 
$
1,336

 
$
1,424

 
$
1,319

 
$
1,190

 
 
$
1,834

 
 
$
5,461

 
$
5,767

 

A-1


 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
APPENDIX
METLIFE
NOTABLE ITEMS (1)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
METLIFE TOTAL (2)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For the Three Months Ended
 
 
For the Year Ended
 
Unaudited (In millions)
 
December 31, 2018

 
March 31, 2019

 
June 30, 2019

 
September 30, 2019

 
 
December 31, 2019

 
 
 
December 31, 2018


December 31, 2019

 
 
Actuarial assumption review and other insurance adjustments
 
$

 
$

 
$

 
$
(160
)
 
 
$

 
 
 
$
(6
)
 
$
(160
)
 
 
Litigation reserves & settlement costs
 
(60
)
 

 

 

 
 

 
 
 
(60
)
 

 
 
Expense initiative costs
 
(100
)
 
(55
)
 
(70
)
 
(88
)
 
 
(119
)
 
 
 
(284
)
 
(332
)
 
 
Interest on tax adjustments
 
170

 

 

 

 
 
64

 
 
 
170

 
64

 
 
Tax adjustments
 
77

 

 

 

 
 
475

 
 
 
77

 
475

 
 
Total notable items
 
$
87

 
$
(55
)
 
$
(70
)
 
$
(248
)
 
 
$
420

 
 
 
$
(103
)
 
$
47

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
U.S.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For the Three Months Ended
 
 
For the Year Ended
 
Unaudited (In millions)
 
December 31, 2018

 
March 31, 2019

 
June 30, 2019

 
September 30, 2019

 
 
December 31, 2019

 
 
 
December 31, 2018

 
December 31, 2019

 
 
Actuarial assumption review and other insurance adjustments
 
$

 
$

 
$

 
$

 
 
$

 
 
 
$
37

 
$

 
 
Total notable items
 
$

 
$

 
$

 
$

 
 
$

 
 
 
$
37

 
$

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
GROUP BENEFITS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For the Three Months Ended
 
 
For the Year Ended
 
 
Unaudited (In millions)
 
December 31, 2018

 
March 31, 2019

 
June 30, 2019

 
September 30, 2019

 
 
December 31, 2019

 
 
 
December 31, 2018

 
December 31, 2019

 
 
 
Actuarial assumption review and other insurance adjustments
 
$

 
$

 
$

 
$

 
 
$

 
 
 
$
37

 
$

 
 
 
Total notable items
 
$

 
$

 
$

 
$

 
 
$

 
 
 
$
37

 
$

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(1) These notable items represent a positive (negative) impact to adjusted earnings available to common shareholders. Notable items reflect the unexpected impact of events that affect MetLife's results, but that were unknown and that MetLife could not anticipate when it devised its Business Plan. Notable items also include certain items regardless of the extent anticipated in the Business Plan to help investors have a better understanding of MetLife's results and to evaluate and forecast those results.
 
 
(2) Certain amounts in prior periods have been reclassified to conform to current period presentation.
 


A-2


 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
APPENDIX
METLIFE
NOTABLE ITEMS (CONTINUED) (1)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ASIA
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
For the Three Months Ended
 
For the Year Ended
 
Unaudited (In millions)
 
December 31, 2018

 
March 31, 2019

 
June 30, 2019

 
September 30, 2019

 
 
December 31, 2019

 
 
 
December 31, 2018

 
 
December 31, 2019

 
 
Actuarial assumption review and other insurance adjustments
 
$

 
$

 
$

 
$
(19
)
 
 
$

 
 
 
$
(86
)
 
 
$
(19
)
 
 
Total notable items
 
$

 
$

 
$

 
$
(19
)
 
 
$

 
 
 
$
(86
)
 
 
$
(19
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LATIN AMERICA
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
For the Three Months Ended
 
For the Year Ended
 
Unaudited (In millions)
 
December 31, 2018

 
March 31, 2019

 
June 30, 2019

 
September 30, 2019

 
 
December 31, 2019

 
 
 
December 31, 2018

 
 
December 31, 2019

 
 
Actuarial assumption review and other insurance adjustments
 
$

 
$

 
$

 
$
10

 
 
$

 
 
 
$
28

 
 
$
10

 
 
Total notable items
 
$

 
$

 
$

 
$
10

 
 
$

 
 
 
$
28

 
 
$
10

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
EMEA
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
For the Three Months Ended
 
For the Year Ended
 
Unaudited (In millions)
 
December 31, 2018

 
March 31, 2019

 
June 30, 2019

 
September 30, 2019

 
 
December 31, 2019

 
 
 
December 31, 2018

 
 
December 31, 2019

 
 
Actuarial assumption review and other insurance adjustments
 
$

 
$

 
$

 
$
(13
)
 
 
$

 
 
 
$
(23
)
 
 
$
(13
)
 
 
Total notable items
 
$

 
$

 
$

 
$
(13
)
 
 
$

 
 
 
$
(23
)
 
 
$
(13
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
METLIFE HOLDINGS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
For the Three Months Ended
 
For the Year Ended
 
Unaudited (In millions)
 
December 31, 2018

 
March 31, 2019

 
June 30, 2019

 
September 30, 2019

 
 
December 31, 2019

 
 
 
December 31, 2018

 
 
December 31, 2019

 
 
Actuarial assumption review and other insurance adjustments
 
$

 
$

 
$

 
$
(138
)
 
 
$

 
 
 
$
38

 
 
$
(138
)
 
 
Total notable items
 
$

 
$

 
$

 
$
(138
)
 
 
$

 
 
 
$
38

 
 
$
(138
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CORPORATE & OTHER (2)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
For the Three Months Ended
 
For the Year Ended
 
 
Unaudited (In millions)
 
December 31, 2018

 
March 31, 2019

 
June 30, 2019

 
September 30, 2019

 
 
December 31, 2019

 
 
 
December 31, 2018

 
 
December 31, 2019

 
 
Litigation reserves & settlement costs
 
$
(60
)
 
$

 
$

 
$

 
 
$

 
 
 
$
(60
)
 
 
$

 
 
Expense initiative costs
 
(100
)
 
(55
)
 
(70
)
 
(88
)
 
 
(119
)
 
 
 
(284
)
 
 
(332
)
 
 
Interest on tax adjustments
 
170

 

 

 

 
 
64

 
 
 
170

 
 
64

 
 
Tax adjustments
 
77

 

 

 

 
 
475

 
 
 
77

 
 
475

 
 
Total notable items
 
$
87

 
$
(55
)
 
$
(70
)
 
$
(88
)
 
 
$
420

 
 
 
$
(97
)
 
 
$
207

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(1) These notable items represent a positive (negative) impact to adjusted earnings available to common shareholders. Notable items reflect the unexpected impact of events that affect MetLife's results, but that were unknown and that MetLife could not anticipate when it devised its Business Plan. Notable items also include certain items regardless of the extent anticipated in the Business Plan to help investors have a better understanding of MetLife's results and to evaluate and forecast those results.
 
 
(2) Certain amounts in prior periods have been reclassified to conform to current period presentation.
 

A-3


 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
APPENDIX
METLIFE
EQUITY DETAILS, BOOK VALUE DETAILS AND RETURN ON EQUITY
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Unaudited (In millions)
December 31, 2018

 
March 31, 2019

 
June 30, 2019

 
September 30, 2019

 
December 31, 2019

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total MetLife, Inc.'s stockholders' equity
$
52,741

 
$
58,509

 
$
63,811

 
$
68,368

 
$
66,144

 
 
 
 
 
 
Less: Preferred stock
3,340

 
3,340

 
3,340

 
3,340

 
3,340

 
 
 
 
 
 
MetLife, Inc.'s common stockholders' equity
49,401

 
55,169

 
60,471

 
65,028

 
62,804

 
 
 
 
 
 
Less: Net unrealized investment gains (losses), net of income tax
8,655

 
13,862

 
18,381

 
22,330

 
19,981

 
 
 
 
 
 
  Defined benefit plans adjustment, net of income tax
(2,028
)
 
(2,004
)
 
(1,984
)
 
(1,961
)
 
(2,002
)
 
 
 
 
 
 
Total MetLife, Inc.'s common stockholders' equity, excluding AOCI other than FCTA
$
42,774

 
$
43,311

 
$
44,074

 
$
44,659

 
$
44,825

 
 
 
 
 
 
Less: Goodwill, net of income tax
9,133

 
9,082

 
9,071

 
8,955

 
8,986

 
 
 
 
 
 
  VODA and VOCRA, net of income tax
312

 
298

 
288

 
279

 
268

 
 
 
 
 
 
Total MetLife, Inc.'s tangible common stockholders' equity
$
33,329

 
$
33,931

 
$
34,715

 
$
35,425

 
$
35,571

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Unaudited (In millions, except per share data)
December 31, 2018

 
March 31, 2019

 
June 30, 2019

 
September 30, 2019

 
December 31, 2019

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Book value per common share
$
51.53

 
$
58.06

 
$
64.61

 
$
70.71

 
$
68.62

 
 
 
 
 
 
Less: Net unrealized investment gains (losses), net of income tax
9.03

 
14.59

 
19.64

 
24.28

 
21.84

 
 
 
 
 
 
  Defined benefit plans adjustment, net of income tax
(2.12
)
 
(2.11
)
 
(2.12
)
 
(2.13
)
 
(2.19
)
 
 
 
 
 
 
Book value per common share, excluding AOCI other than FCTA
$
44.62

 
$
45.58

 
$
47.09

 
$
48.56

 
$
48.97

 
 
 
 
 
 
Less: Goodwill, net of income tax
9.52

 
9.56

 
9.69

 
9.74

 
9.82

 
 
 
 
 
 
  VODA and VOCRA, net of income tax
0.33

 
0.31

 
0.31

 
0.30

 
0.29

 
 
 
 
 
 
Book value per common share - tangible common stockholders' equity
$
34.77

 
$
35.71

 
$
37.09

 
$
38.52

 
$
38.86

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Common shares outstanding, end of period
958.6

 
950.2

 
935.9

 
919.6

 
915.3

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For the Three Months Ended (1)
 
For the Year Ended
 
Unaudited (In millions, except ratios)
December 31, 2018

 
March 31, 2019

 
June 30, 2019

 
September 30, 2019

 
December 31, 2019

 
 
December 31, 2018

 
December 31, 2019

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Return on MetLife, Inc.'s:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Common stockholders' equity
16.5
%
 
10.3
%
 
11.6
%
 
13.7
%
 
3.4
%
 
 
9.6
%
 
9.8
%
 
Common stockholders' equity, excluding AOCI other than FCTA
18.9
%
 
12.5
%
 
15.4
%
 
19.4
%
 
4.8
%
 
 
11.5
%
 
13.0
%
 
Tangible common stockholders' equity (2)
24.4
%
 
16.2
%
 
19.7
%
 
24.6
%
 
6.1
%
 
 
14.8
%
 
16.6
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted return on MetLife, Inc.'s:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Common stockholders' equity
10.9
%
 
10.9
%
 
9.1
%
 
7.6
%
 
11.5
%
 
 
10.6
%
 
9.8
%
 
Common stockholders' equity, excluding AOCI other than FCTA
12.5
%
 
13.2
%
 
12.1
%
 
10.7
%
 
16.4
%
 
 
12.6
%
 
13.1
%
 
Tangible common stockholders' equity (2)
16.2
%
 
17.1
%
 
15.5
%
 
13.7
%
 
20.7
%
 
 
16.3
%
 
16.8
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Average common stockholders' equity
$
48,843

 
$
52,285

 
$
57,820

 
$
62,750

 
$
63,916

 
 
$
51,668

 
$
58,575

 
Average common stockholders' equity, excluding AOCI other than FCTA
$
42,582

 
$
43,043

 
$
43,693

 
$
44,367

 
$
44,742

 
 
$
43,427

 
$
43,929

 
Average tangible common stockholders' equity
$
33,128

 
$
33,630

 
$
34,323

 
$
35,070

 
$
35,498

 
 
$
33,838

 
$
34,594

 
 
 
 
 
 
 
(1) Annualized using quarter-to-date results.
 
(2) Net income (loss) available to MetLife, Inc.'s common shareholders and adjusted earnings available to common shareholders used to calculate returns on tangible common stockholders' equity, exclude the impact of amortization of VODA and VOCRA, net of income tax, for the three months ended December 31, 2018, March 31, 2019, June 30, 2019, September 30, 2019 and December 31, 2019 of $9 million, $10 million, $9 million, $9 million and $6 million, respectively, and for the years ended December 31, 2018 and 2019 of $39 million and $34 million, respectively.

A-4


 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
APPENDIX
METLIFE
ADJUSTED PREMIUMS, FEES AND OTHER REVENUES, OTHER EXPENSES AND ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS - CONSTANT CURRENCY BASIS
 
 
 
 
 
 ADJUSTED PREMIUMS, FEES AND OTHER REVENUES, ON A CONSTANT CURRENCY BASIS
 
 
 
 
 
 
 
 
 
 
 
For the Three Months Ended
 
 
Unaudited (In millions)
 
 
December 31, 2018

 
 
March 31, 2019

 
 
June 30, 2019

 
 
September 30, 2019

 
 
December 31, 2019

 
 
U.S. (1)
 
 
$
5,725

 
 
$
6,058

 
 
$
6,731

 
 
$
7,391

 
 
$
8,586

 
 
ASIA
 
 
2,128

 
 
2,119

 
 
2,073

 
 
2,083

 
 
2,080

 
 
LATIN AMERICA
 
 
926

 
 
893

 
 
1,013

 
 
944

 
 
888

 
 
EMEA
 
 
636

 
 
652

 
 
668

 
 
660

 
 
670

 
 
METLIFE HOLDINGS (1)
 
 
1,385

 
 
1,268

 
 
1,275

 
 
1,261

 
 
1,321

 
 
CORPORATE & OTHER (1)
 
 
219

 
 
119

 
 
98

 
 
72

 
 
87

 
 
Adjusted premiums, fees and other revenues, on a constant currency basis
 
 
$
11,019

 
 
$
11,109

 
 
$
11,858

 
 
$
12,411

 
 
$
13,632

 
 
Adjusted premiums, fees and other revenues
 
 
$
11,022

 
 
$
11,167

 
 
$
11,900

 
 
$
12,445

 
 
$
13,632

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ASIA (including operating joint ventures) (2), (3)
 
 
$
2,376

 
 
$
2,360

 
 
$
2,349

 
 
$
2,332

 
 
$
2,359

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 OTHER EXPENSES ON A CONSTANT CURRENCY BASIS
 
 
 
 
 
 
 
 
 
 
 
For the Three Months Ended
 
 
Unaudited (In millions)
 
 
December 31, 2018

 
 
March 31, 2019

 
 
June 30, 2019

 
 
September 30, 2019

 
 
December 31, 2019

 
 
U.S. (1)
 
 
$
994

 
 
$
993

 
 
$
1,009

 
 
$
1,004

 
 
$
1,069

 
 
ASIA
 
 
987

 
 
957

 
 
959

 
 
948

 
 
953

 
 
LATIN AMERICA
 
 
359

 
 
348

 
 
338

 
 
349

 
 
369

 
 
EMEA
 
 
351

 
 
334

 
 
349

 
 
342

 
 
370

 
 
METLIFE HOLDINGS (1)
 
 
266

 
 
227

 
 
237

 
 
223

 
 
282

 
 
CORPORATE & OTHER (1)
 
 
102

 
 
222

 
 
289

 
 
320

 
 
243

 
 
Other expenses, as reported on an adjusted basis, on a constant currency basis
 
 
$
3,059

 
 
$
3,081

 
 
$
3,181

 
 
$
3,186

 
 
$
3,286

 
 
Other expenses, as reported on an adjusted basis
 
 
$
3,055

 
 
$
3,101

 
 
$
3,192

 
 
$
3,199

 
 
$
3,286

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ASIA (including operating joint ventures) (2), (3)
 
 
$
1,093

 
 
$
1,060

 
 
$
1,065

 
 
$
1,051

 
 
$
1,064

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS ON A CONSTANT CURRENCY BASIS
 
 
 
 
 
 
 
 
 
 
 
For the Three Months Ended
 
 
Unaudited (In millions)
 
 
December 31, 2018

 
 
March 31, 2019

 
 
June 30, 2019

 
 
September 30, 2019

 
 
December 31, 2019

 
 
U.S. (1)
 
 
$
685

 
 
$
724

 
 
$
732

 
 
$
707

 
 
$
675

 
 
ASIA
 
 
278

 
 
351

 
 
357

 
 
350

 
 
341

 
 
LATIN AMERICA
 
 
133

 
 
125

 
 
151

 
 
151

 
 
161

 
 
EMEA
 
 
54

 
 
84

 
 
77

 
 
53

 
 
66

 
 
METLIFE HOLDINGS (1)
 
 
223

 
 
317

 
 
299

 
 
149

 
 
269

 
 
CORPORATE & OTHER (1)
 
 
(45
)
 
 
(193
)
 
 
(307
)
 
 
(223
)
 
 
322

 
 
Adjusted earnings available to common shareholders on a constant currency basis
 
 
$
1,328

 
 
$
1,408

 
 
$
1,309

 
 
$
1,187

 
 
$
1,834

 
 
Adjusted earnings available to common shareholders
 
 
$
1,336

 
 
$
1,424

 
 
$
1,319

 
 
$
1,190

 
 
$
1,834

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 (1) Amounts on a reported basis, as constant currency impact is not significant.
 
 (2) Adjusted premiums, fees and other revenues as well as other expenses are reported as part of net investment income on the statement of adjusted earnings available to common shareholders for operating joint ventures.
 
 
 (3) Includes MetLife, Inc.'s percentage interest in operating joint ventures of: (i) China, (ii) India, (iii) Malaysia and (iv) Vietnam, which are consolidated using the equity method of accounting.

A-5


 
 
 
 
 
 
METLIFE
NON-GAAP AND OTHER FINANCIAL DISCLOSURES

In this QFS, MetLife presents certain measures of its performance on a consolidated and segment basis that are not calculated in accordance with GAAP. We believe that these non-GAAP financial measures enhance the understanding of our performance by highlighting the results of operations and the underlying profitability drivers of our business. Segment-specific financial measures are calculated using only the portion of consolidated results attributable to that specific segment.

The following non-GAAP financial measures should not be viewed as substitutes for the most directly comparable financial measures calculated in accordance with GAAP:
 
Non-GAAP financial measures:
Comparable GAAP financial measures:
 
(i)
total adjusted revenues
(i)
total revenues
 
(ii)
total adjusted expenses
(ii)
total expenses
 
(iii)
adjusted premiums, fees and other revenues
(iii)
premiums, fees and other revenues
 
(iv)
adjusted premiums, fees & other revenues, excluding PRT
(iv)
premiums, fees and other revenues
 
(v)
net investment income, as reported on an adjusted basis
(v)
net investment income
 
(vi)
adjusted earnings
(vi)
income (loss) from continuing operations, net of income tax
 
(vii)
adjusted earnings available to common shareholders
(vii)
net income (loss) available to MetLife, Inc.’s common shareholders
 
(viii)
adjusted earnings available to common shareholders per diluted common share
(viii)
net income (loss) available to MetLife, Inc.’s common shareholders per diluted common share
 
(ix)
adjusted return on equity
(ix)
return on equity
 
(x)
adjusted return on equity, excluding AOCI other than FCTA
(x)
return on equity
 
(xi)
adjusted tangible return on equity
(xi)
return on equity
 
(xii)
investment portfolio gains (losses)
(xii)
net investment gains (losses)
 
(xiii)
derivative gains (losses)
(xiii)
net derivative gains (losses)
 
(xiv)
capitalization of DAC, as reported on an adjusted basis
(xiv)
capitalization of DAC
 
(xv)
total MetLife, Inc.’s tangible common stockholders’ equity
(xv)
total MetLife, Inc.’s stockholders’ equity
 
(xvi)
total MetLife, Inc.’s common stockholders’ equity, excluding AOCI other than FCTA
(xvi)
total MetLife, Inc.’s stockholders’ equity
 
(xvii)
book value per common share, excluding AOCI other than FCTA
(xvii)
book value per common share
 
(xviii)
book value per common share - tangible common stockholders' equity
(xviii)
book value per common share
 
(xix)
other expenses, as reported on an adjusted basis
(xix)
other expenses
 
(xx)
other expenses, net of capitalization of DAC, as reported on an adjusted basis
(xx)
other expenses, net of capitalization of DAC
 
(xxi)
other expenses, net of capitalization of DAC, excluding total notable items related to other expenses, as reported on an adjusted basis
(xxi)
other expenses, net of capitalization of DAC
 
(xxii)
adjusted expense ratio
(xxii)
expense ratio
 
(xxiii)
adjusted expense ratio, excluding total notable items related to other expenses and PRT
(xxiii)
expense ratio
 
(xxiv)
direct expenses
(xxiv)
other expenses
 
(xxv)
direct expenses, excluding total notable items related to direct expenses
(xxv)
other expenses
 
(xxvi)
direct expense ratio
(xxvi)
expense ratio
 
(xxvii)
direct expense ratio, excluding total notable items related to direct expenses and PRT
(xxvii)
expense ratio
 
(xxviii)
GA AUM
(xxviii)
total investments
 
(xxix)
GA AUM (excluding FVA)
(xxix)
total investments
 
 
 
 
 
 
Any of these financial measures shown on a constant currency basis reflect the impact of changes in foreign currency exchange rates and are calculated using the average foreign currency exchange rates for the most recent period. As a result, comparable prior period amounts are updated each period to reflect the most recent period average foreign currency exchange rates.
 
Reconciliations of these non-GAAP financial measures to the most directly comparable GAAP financial measures are included in this QFS and in this period’s earnings news release which is available at www.metlife.com.

Our definitions of non-GAAP and other financial measures discussed in this QFS may differ from those used by other companies:

Adjusted earnings and related measures
 
adjusted earnings;
 
adjusted earnings available to common shareholders;
 
adjusted earnings available to common shareholders per diluted common share; and
 
adjusted earnings available to common shareholders on a constant currency basis.
 
These measures are used by management to evaluate performance and allocate resources. Consistent with GAAP guidance for segment reporting, adjusted earnings and components of, or other financial measures based on, adjusted earnings are also MetLife’s GAAP measures of segment performance. Adjusted earnings and other financial measures based on adjusted earnings are also the measures by which MetLife senior management’s and many other employees’ performance is evaluated for the purposes of determining their compensation under applicable compensation plans. Adjusted earnings and other financial measures based on adjusted earnings allow analysis of MetLife's performance relative to its Business Plan and facilitate comparisons to industry results.

Adjusted earnings is defined as adjusted revenues less adjusted expenses, net of income tax. Adjusted earnings available to common shareholders is defined as adjusted earnings less preferred stock dividends.

A-6


 
 
 
 
 
 
 
 
 
 
 
METLIFE
NON-GAAP AND OTHER FINANCIAL DISCLOSURES (CONTINUED)
 
Adjusted revenues and adjusted expenses
 
These financial measures, along with the related adjusted premiums, fees and other revenues, focus on our primary businesses principally by excluding the impact of market volatility, which could distort trends, and revenues and costs related to non-core products and certain entities required to be consolidated under GAAP. Also, these measures exclude results of discontinued operations under GAAP and other businesses that have been or will be sold or exited by MetLife but do not meet the discontinued operations criteria under GAAP (“Divested businesses”). Divested businesses also includes the net impact of transactions with exited businesses that have been eliminated in consolidation under GAAP and costs relating to businesses that have been or will be sold or exited by MetLife that do not meet the criteria to be included in results of discontinued operations under GAAP. Adjusted revenues also excludes NIGL and NDGL. Adjusted expenses also excludes goodwill impairments.
 
 
 
The following additional adjustments are made to revenues, in the line items indicated, in calculating adjusted revenues:
 
Universal life and investment-type product policy fees excludes the amortization of unearned revenue related to NIGL and NDGL (“Unearned revenue adjustments”) and certain variable annuity GMIB fees (“GMIB fees”);
 
Net investment income: (i) includes adjustments for earned income on derivatives and amortization of premium on derivatives that are hedges of investments or that are used to replicate certain investments but do not qualify for hedge accounting treatment (“Investment hedge adjustments”), (ii) excludes post-tax adjusted earnings adjustments relating to insurance joint ventures accounted for under the equity method (“Operating joint venture adjustments”), (iii) excludes certain amounts related to contractholder-directed equity securities (“Unit-linked contract income”), (iv) excludes certain amounts related to securitization entities that are VIEs consolidated under GAAP (“Securitization entities income”), and (v) includes distributions of profits from certain other limited partnership interests that were previously accounted for under the cost method, but are now accounted for at estimated fair value, where the change in estimated fair value is recognized in NIGL under GAAP ("Certain partnership distributions"); and
 
Other revenues is adjusted for settlements of foreign currency earnings hedges and excludes fees received in association with services provided under transition service agreements ("TSA fees").
 
 
 
The following additional adjustments are made to expenses, in the line items indicated, in calculating adjusted expenses:
 
Policyholder benefits and claims and policyholder dividends excludes: (i) amortization of basis adjustments associated with de-designated fair value hedges of future policy benefits ("PBC hedge adjustments"), (ii) changes in the policyholder dividend obligation related to NIGL and NDGL (“PDO adjustments”), (iii) inflation-indexed benefit adjustments associated with contracts backed by inflation-indexed investments and amounts associated with periodic crediting rate adjustments based on the total return of a contractually referenced pool of assets and other pass-through adjustments (“Inflation and pass-through adjustments”), (iv) benefits and hedging costs related to GMIBs (“GMIB costs”), and (v) market value adjustments associated with surrenders or terminations of contracts (“Market value adjustments”);
 
Interest credited to policyholder account balances includes adjustments for earned income on derivatives and amortization of premium on derivatives that are hedges of policyholder account balances but do not qualify for hedge accounting treatment (“PAB hedge adjustments”) and excludes certain amounts related to net investment income earned on contractholder-directed equity securities (“Unit-linked contract costs”);
 
Amortization of DAC and VOBA excludes amounts related to: (i) NIGL and NDGL, (ii) GMIB fees and GMIB costs, and (iii) Market value adjustments;
 
Amortization of negative VOBA excludes amounts related to Market value adjustments;
 
Interest expense on debt excludes certain amounts related to securitization entities that are VIEs consolidated under GAAP (“Securitization entities debt expense”); and
 
Other expenses excludes: (i) noncontrolling interests, (ii) implementation of new insurance regulatory requirements costs (“Regulatory implementation costs”) and (iii) acquisition, integration and other costs. Other expenses includes TSA fees.
 
 
 
 
 
 
Adjusted earnings also excludes the recognition of certain contingent assets and liabilities that could not be recognized at acquisition or adjusted for during the measurement period under GAAP business combination accounting guidance.

The tax impact of the adjustments mentioned above are calculated net of the U.S. or foreign statutory tax rate, which could differ from MetLife's effective tax rate. Additionally, the provision for income tax (expense) benefit also includes the impact related to the timing of certain tax credits, as well as certain tax reforms.
 
Investment portfolio gains (losses) and derivative gains (losses)

These are measures of investment and hedging activity. Investment portfolio gains (losses) principally excludes amounts that are reported within net investment gains (losses) but do not relate to the performance of the investment portfolio, such as gains (losses) on sales and divestitures of businesses, goodwill impairment or changes in estimated fair value. Derivative gains (losses) principally excludes earned income on derivatives and amortization of premium on derivatives, where such derivatives are either hedges of investments or are used to replicate certain investments, and where such derivatives do not qualify for hedge accounting. This earned income and amortization of premium is reported within adjusted earnings and not within derivative gains (losses).
 
 

A-7



 
 
 
 
 
 
 
 
 
 
 
METLIFE
NON-GAAP AND OTHER FINANCIAL DISCLOSURES (CONTINUED)
 
Return on equity, allocated equity, tangible equity and related measures
 
Total MetLife, Inc.’s common stockholders’ equity, excluding AOCI other than FCTA: Total MetLife, Inc.’s common stockholders’ equity, excluding the net unrealized investment gains (losses) and defined benefit plans adjustment components of AOCI, net of income tax.
 
Return on MetLife, Inc.’s common stockholders’ equity: net income (loss) available to MetLife, Inc.’s common shareholders divided by MetLife, Inc.'s average common stockholders’ equity.
 
Return on MetLife, Inc.’s common stockholders’ equity, excluding AOCI other than FCTA : net income (loss) available to MetLife, Inc.’s common shareholders divided by MetLife, Inc.'s average common stockholders’ equity, excluding AOCI other than FCTA.
 
Adjusted return on MetLife, Inc.’s common stockholders’ equity: adjusted earnings available to common shareholders divided by MetLife, Inc.'s average common stockholders’ equity.
 
Adjusted return on MetLife, Inc.’s common stockholders’ equity, excluding AOCI other than FCTA: adjusted earnings available to common shareholders divided by MetLife, Inc.'s average common stockholders’ equity, excluding AOCI other than FCTA.
 
Adjusted return on MetLife, Inc.’s common stockholders’ equity, excluding net equity of assets and liabilities of disposed subsidiary (excludes AOCI other than FCTA): adjusted earnings available to common shareholders divided by MetLife, Inc.’s average common stockholders’ equity, excluding net equity of assets and liabilities of disposed subsidiary (excludes AOCI other than FCTA).
 
Allocated equity: portion of MetLife, Inc.’s common stockholders’ equity that management allocates to each of its segments and sub-segments based on local capital requirements and economic capital. Economic capital is an internally developed risk capital model, the purpose of which is to measure the risk in the business and to provide a basis upon which capital is deployed. MetLife management periodically reviews this model to ensure that it remains consistent with emerging industry practice standards and the local capital requirements; allocated equity may be adjusted if warranted by such review. Allocated equity excludes the impact of AOCI other than FCTA.
 
Adjusted return on allocated equity: adjusted earnings available to common shareholders divided by allocated equity.
 
 
The above measures represent a level of equity consistent with the view that, in the ordinary course of business, we do not plan to sell most investments for the sole purpose of realizing gains or losses. Also, refer to the utilization of adjusted earnings and components of, or other financial measures based on, adjusted earnings mentioned above.
 
Total MetLife, Inc.’s tangible common stockholders’ equity or tangible equity: Total MetLife, Inc.’s common stockholders’ equity, excluding AOCI other than FCTA, reduced by the impact of goodwill, VODA and VOCRA, all net of income tax.
 
Return on MetLife, Inc.’s tangible common stockholders’ equity: net income (loss) available to MetLife, Inc.’s common shareholders, excluding amortization of VODA and VOCRA, net of income tax, divided by MetLife, Inc.'s average tangible common stockholders’ equity.
 
Adjusted return on MetLife, Inc.’s tangible common stockholders’ equity: adjusted earnings available to common shareholders, excluding amortization of VODA and VOCRA, net of income tax, divided by MetLife, Inc.’s average tangible common stockholders’ equity.
 
Allocated tangible equity: Allocated equity reduced by the impact of goodwill, VODA and VOCRA, all net of income tax.
 
Adjusted return on allocated tangible equity: adjusted earnings available to common shareholders, excluding amortization of VODA and VOCRA, net of income tax, divided by allocated tangible equity.
 
 
The above measures are, when considered in conjunction with regulatory capital ratios, a measure of capital adequacy.
 
 
 
Expense ratio, direct expense ratio, adjusted expense ratio and related measures
 
Expense ratio: other expenses, net of capitalization of DAC, divided by premiums, fees and other revenues.
 
Direct expense ratio: direct expenses, on an adjusted basis, divided by adjusted premiums, fees and other revenues.
 
Direct expense ratio, excluding total notable items related to direct expenses and PRT: direct expenses, on an adjusted basis, excluding total notable items related to direct expenses, divided by adjusted premiums, fees and other revenues, excluding PRT.
 
Adjusted expense ratio: other expenses, net of capitalization of DAC, both on an adjusted basis, divided by adjusted premiums, fees and other revenues.
 
Adjusted expense ratio, excluding total notable items related to other expenses and PRT: other expenses, net of capitalization of DAC, both on an adjusted basis, excluding total notable items related to other expenses, divided by adjusted premiums, fees and other revenues, excluding PRT.
 
 
 
General account assets under management and related measures
 
GA AUM is used by MetLife to describe assets in its GA investment portfolio which are actively managed and stated at estimated fair value. MetLife believes the use of GA AUM enhances the understanding and comparability of its GA investment portfolio. GA AUM is comprised of GA total investments and cash and cash equivalents, excluding policy loans, other invested assets, contractholder-directed equity securities and fair value option securities, as substantially all of these assets are not actively managed in MetLife’s GA investment portfolio. Mortgage loans and real estate and real estate joint ventures included in GA AUM (at net asset value, net of deduction for encumbering debt) have been adjusted from carrying value to estimated fair value. At the segment level, intersegment balances (intercompany activity, primarily related to investments in subsidiaries, that eliminate at the MetLife consolidated level) are excluded from GA AUM.
 

GA AUM (excluding FVA) excludes the following FVA: (i) unrealized gain (loss) on investments carried at estimated fair value and (ii) adjustments from carrying value to estimated fair value on mortgage loans and real estate and real estate joint ventures. MetLife believes that the use of GA AUM (excluding FVA) enhances the understanding of the value of GA AUM without regard to the impact of market volatility.
 
 
 
Other items
 
The following additional information is relevant to an understanding of our performance results:
 
Statistical sales information for Latin America, Asia and EMEA: calculated using 10% of single-premium deposits (mainly from retirement products such as variable annuity, fixed annuity and pensions), 20% of single-premium deposits from credit insurance and 100% of annualized full-year premiums and fees from recurring-premium policy sales of all products (mainly from risk and protection products such as individual life, accident & health and group). Sales statistics do not correspond to revenues under GAAP, but are used as relevant measures of business activity.

A-8


 
 
 
 
METLIFE
ACRONYMS
 
 
 
 
AOCI
Accumulated other comprehensive income (loss)
 
CSE
Consolidated securitization entity
 
DAC
Deferred policy acquisition costs
 
EMEA
Europe, the Middle East and Africa
 
FVA
Fair value adjustments
 
FCTA
Foreign currency translation adjustments
 
GA
General account
 
GA AUM
General account assets under management
 
GAAP
Accounting principles generally accepted in the United States of America
 
GICs
Guaranteed interest contracts
 
GMIB
Guaranteed minimum income benefits
 
NAIC
National Association of Insurance Commissioners
 
NDGL
Net derivative gains (losses)
 
NIGL
Net investment gains (losses)
 
NRSRO
Nationally Recognized Statistical Rating Organizations
 
PAB
Policyholder account balances
 
PBC
Policyholder benefits and claims
 
PDO
Policyholder dividend obligation
 
PRT
Pension risk transfers
 
QFS
Quarterly financial supplement
 
TSA
Transition service agreement
 
VIE
Variable interest entity
 
VOBA
Value of business acquired
 
VOCRA
Value of customer relationships acquired
 
VODA
Value of distribution agreements

A-9



imagj95.jpg
navigatinglifetogethera01.jpg